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Homologous recombination (HR) is an essential mechanism for accurate repair of DNA 
double-strand breaks (DSBs). However, HR must be tightly controlled because excessive or 
unwanted HR events can lead to genome instability, which is a prerequisite for premature 
aging and cancer development. A critical step of HR is the loading of RAD51 molecules onto 
single-stranded DNA regions generated in the vicinity of the DSB, leading to the formation of 
a nucleoprotein filament. Several DNA helicases have been involved in the regulation of the 
HR process. One of these is human FBH1 (F-box DNA helicase 1) that is a member of SF1 
superfamily of helicases. As a unique DNA helicase, FBH1 additionally possesses a conserved 
F-box motif that allows it to assemble into an SCF complex, an E3 ubiquitin ligase that targets 
proteins for degradation. FBH1 has been implicated in the restriction of nucleoprotein filament 
stability. However, the exact mechanism of how FBH1 controls the RAD51 action is still not 
certain. In this work, we revealed that FBH1 actively disassembles RAD51 nucleoprotein 
filament. We also show that FBH1 interacts with RAD51 and RPA physically in vitro. Based 
on these data, we propose a potential mechanism of FBH1 antirecombinase function. 
 
 








Homologní rekombinace (HR) je mechanismus nezbytný pro bezchybnou opravu 
dvouvláknových zlomů v DNA. Tento proces musí být přísně regulován, protože nadměrné 
množství nežádoucích HR může v buňce vést k nestabilitě genomu, od které je už jen krůček k 
symptomu předčasnému stárnutí či vývoji zhoubných onkologických onemocnění. 
Rozhodujícím krokem v procesu HR je tvorba tzv. presynaptického filamentu. Ten vzniká po 
navázání molekul RAD51 na úsek jednořetězcové DNA, který se vytvoří v okolí 
dvouvláknových zlomů. Proces HR je kontrolován mj. DNA helikázami. Mezi nimi je i lidská 
FBH1 (F-box DNA helicase 1) ze SF1 rodiny helikáz. Jedinečným znakem FBH1 helikázy je 
přítomnost konzervovaného F-box motivu. Díky němu se FBH1 váže v SCF komplexu 
fungujícího jako E3 ubiquitin ligáza, která určuje proteiny pro degradaci. V procesu HR plní 
FBH1 úlohu v regulaci stability presynaptického filamentu. Ovšem přesný mechanismus jak 
FBH1 kontroluje činnost RAD51 ještě nebyl zcela popsán. V této diplomové práci jsme 
ukázali, že FBH1 helikáza aktivně rozrušuje RAD51 presynaptický filament. Dále jsme 
in vitro odhalili přímou interakci FBH1 s RAD51 a RPA. Na základě našich výsledků jsme 
navrhli možný model mechanismu antirekombinázové funkce FBH1 helikázy.  
 
 








aa   amino acid 
ATM kinase  ataxia telangiectasia mutated kinase 
ATP   adenosine triphosphate 
ATR kinase   ataxia telangiectasia and Rad3-related kinase 
BCA   bicinchoninic acid 
BER   base-excision repair 
BLM   Bloom helicase 
BSA   bovine serum albumine 
CBD   chitin binding domain 
co-IP   complex protein-immunoprecipitation 
CTP   cytidine triphosphate 
dHJ   double Holliday junction 
D-loop   displacement loop 
dATP   deoxyadenosine triphosphate 
dCTP   deoxycytidine triphosphate 
dGTP   deoxyguanosine triphosphate 
DMEM  Dulbecco's modified Eagle medium 
DNA-PK   DNA-dependent protein kinase 
dNTP   deoxyribonucleotide triphosphate 
dsDNA  double-stranded DNA 
DSB   double-strand break 
DSBR   double-strand break repair 
DTT   dithiotreitol 
dTTP   deoxythymidine triphosphate 
ECL   enhanced chemiluminescence 
EDTA   ethylenediaminetetraacetic acid 
Fbh1   Schizosaccharomyces pombe F-box DNA helicase 1 
FBH1   human F-box DNA helicase 1 
FBH1D698N  ATPase-dead variant of FBH1 
FBS   fetal bovine serum 
GSH   glutathione 
GST   glutathione S-transferase 
GTP   guanosine triphosphate 
His6x   histidine tag 
HJ   Holliday junction 
HR   homologous recombination 
HRP   horseradish peroxidase 
Ig   immunoglobulin 
IPTG   isopropyl-beta-D-thiogalactopyranoside 
LB   Luria Broth 
MMR   mismatch repair 
MRN complex  MRE11/RAD50/NBS1 complex 




NHEJ   non-homologous end joining 
NHS   N-hydroxysuccinimide   
NTP   ribonucleotide triphosphate 
OD600   optical density at 600 nm 
PBS   phosphate buffer saline 
PCR   polymerase chain reaction 
PEG   polyethylenglycol 
Pi   inorganic phosphate 
PMSF   phenylmethylsulfonyl fluoride 
PVDF   polyvinylidine fluoride 
RAD51K133R  ATPase-dead variant of RAD51 
RE   restriction enzyme 
RNAi   RNA interference 
RPA   replication protein A 
RT   room temperature 
SCE   sister chromatid exchange 
SCF complex  Skp1-Cullin-F-box complex 
SCFFBH1  FBH1 in SCF complex 
SDS   sodium dodecyl sulfate 
SDS-PAGE  sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SDSA   synthesis dependent strand annealing 
SF   superfamily 
siRNA   small interfering RNA 
SSB   single-stranded binding protein 
ssDNA   single-stranded DNA 
TEMED  tetramethylethylenediamine 
UTP   uridine triphosphate 
v/v   volume/volume percentage 
w/v   weight/volume percentage 
WCE   whole cell extract 
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An indisputable goal of each living organism is to produce offspring and hand over its genetic 
material to the next generation. From the perspective of evolution, the fundamental process 
that drives biological diversity, certain degree of genomic alteration is an advantage. However, 
at the level of the individual, intact genetic information is required to guard against diseases, 
and thus crucial for survival of all organisms.  
Genome integrity is constantly challenged by genotoxic stress. DNA damage can arise 
spontaneously during normal DNA metabolism or be induced by various endogenous and 
exogenous factors. Their potential deleterious effect to the DNA integrity is unpredictable. 
While some DNA lesions are considered to be relatively benign, other lesions can be quite 
toxic. Then even a single base change in an important gene may have ongoing and catastrophic 
effect on the health and viability of an organism. Moreover, DNA lesion is not a rare event. 
For example, it has been estimated that a single day in the sun can induce up to 105 DNA 
lesions per cell per day (Hoeijmakers, 2009). 
Because DNA is the repository of genetic information in each cell, maintenance of its 
integrity and stability are essential. Cells have therefore evolved a number of strategies to 
sense and repair various types of damage that can occur to DNA.  
Homologous recombination (HR) is, beside its essential role in meiosis and antibody 
variation, one of the key mechanisms that promotes repair of DNA double-strand breaks 
(DSB), the most harmful DNA lesion. If left unrepaired, DSBs can trigger mutagenic accidents 
such as chromosome loss, duplication or translocation, events that can lead to carcinogenesis 
and/or cell death. Although, HR is undoubtedly a beneficial for genome maintenance, 
excessive and unscheduled HR events can be harmful as well. Hence, tight control of HR 
events to balance between these two consequences is essential for viability of an organism.  
Many proteins have been found to be involved in the HR process. Among them, several 
DNA helicases play crucial roles in regulation of HR. So called “prorecombinases” function to 
mediate the repair progression, on the other hand, “antirecombinases” are believed to suppress 
the recombination events.  
DNA helicases are motor proteins that utilize energy from NTP hydrolyses to 
translocate on DNA. They pose an important enzymatic tool involved in almost all biological 
processes where complementary nucleic acid strands have to be separated. The majority of 
helicases are able to disconnect strands in double-stranded DNA (dsDNA), selected few are 
additionally endowed with the ability to remove proteins from either single-stranded DNA 




diseases sharing common features such as genome instability, premature aging and cancer 
predispositions (Hoeijmakers, 2001).  
One of the novel putative player in the repair pathway by HR is F-box DNA helicase 1 
(FBH1) (Kim et al., 2002). FBH1 accumulates at sites of DNA damage where it acts as 
regulator of HR repair in Schizosaccharomyces pombe and human cells. When depleted, the 
cells display an increased sensitivity to DNA-damaging agents (Morishita et al., 2005, Osman 
et al., 2005). FBH1 is suggested to have antirecombinase function by preventing assembly of 
nucleoprotein filament, a key structure in HR. However, the mechanism how FBH1 operates in 
the process of HR remains to be established.  
Besides the helicase domain, FBH1 possesses an additional F-box motif which allows 
it to act within a SCF (Skp1-Cullin-F-box) complex as a ubiquitin ligase and target proteins for 
degradation.  
In this Master thesis, I first provide an overview of current knowledge regarding the 
DSB repair, HR and FBH1 protein. In the experimental part, we provide further 
characterization of FBH1 as an antirecombinase. 
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2 Current state of knowledge 
2.1 DNA damage and DNA damage repair 
Our genomic material is constantly threatened by various harmful factors, both exogenous and 
endogenous. Ultraviolet light and ionizing radiation coming from the cosmos, x-rays, 
numerous genotoxic chemicals including alkylating agents and polycyclic aromatic 
hydrocarbons present in cigarette smoke, can have dangerous consequences to the DNA 
structure (Hoeijmakers, 2001). For example, mitomycin C, a chemotherapy agent, induces 
covalent links between DNA bases on the same or on the opposite DNA strands causing DNA 
lesions termed intrastrand and interstrand cross-links, respectively (Noll et al., 2006). Beside 
the environmental sources of DNA damage, also products of normal cellular metabolism, such 
as free radicals and reactive oxygen species, can have harmful effect on the cellular DNA, for 
instance, by generating DNA breaks (Hoeijmakers, 2009). In addition, DNA replication is a 
common source of DNA insults, e.g. misincorporated bases (Kunkel, 2004) or stalled 
replication fork can result in DNA breakage. Furthermore, DNA molecules are susceptible to 
spontaneous chemical reactions, mostly hydrolysis.  
It is therefore not surprising that multiple efficient detection and repair reactions 
specific for many of lesions have evolved (Figure 1). For instance, mispaired DNA bases are 
corrected by mismatch repair (MMR), small chemical alteration of DNA bases or single-strand 
breaks are repaired by base-excision repair (BER) through excision of the damaged base 
(Jiricny, 2006). More complex lesions, such as pyrimidine dimers, bulky adduct and 
intrastrand cross-links, are corrected by nucleotide-excision repair (NER), through the removal 
of an oligonucleotide containing the damaged bases (Hoeijmakers, 2009, Moldovan and 
D'Andrea, 2009). DSBs and interstrand cross-links are repaired either by non-homologous end 
joining (NHEJ) or by HR (Hiom, 2010).  
As the topic of this thesis deals with the regulatory role of FBH1 helicase in HR, this 
repair pathway is described in detail in following chapter. 
 
 




Figure 1  Illustration of DNA damage and repair mechanisms. 
Common DNA damaging factors (top); examples of DNA lesions caused by these factors (middle); 
and repair mechanism responsible for removal of the lesions (bottom). ROS, reactive oxygen 




2.2 Repair of DNA double-strand breaks by homologous 
recombination 
DSB is the most toxic form of DNA lesion in the cell. Inappropriate repair of broken DNA 
strands may result in generation of harmful genomic rearrangements, such as DNA 
translocations that are common in many tumors. Although DSBs are often considered by the 
cell as DNA damage that needs to be repaired, there are several specialized cellular processes 
that generate DSB as part of normal programmed genomic rearrangement. Examples of this are 
V(D)J recombination, which is important for production of a diverse antibody repertoire in the 
immune system (Soulas-Sprauel et al., 2007), class-switch recombination, which is responsible 
Current state of knowledge 
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for the creation of antibody isotypes (Bransteitter et al., 2006) or recombination between 
homologous chromosomes in meioses (Neale and Keeney, 2006). Unscheduled DSBs pose a 
serious threat for the cell. They must be repaired quickly and with sufficient accuracy to 
restore the integrity and functionality of the genome.  
As mentioned above, cell has two main pathways to correct DSBs: NHEJ and HR. The 
most straightforward way to repair a DSB is simply to rejoin the broken ends regardless of the 
genetic sequence at the break. This process is called NHEJ. The ends of the broken DNA are 
recognized and targeted for NHEJ through the high affinity binding of the heterodimeric 
Ku70/80 complex (Mimori and Hardin, 1986) and processed to join directly (Pfeiffer and 
Vielmetter, 1988, Thode et al., 1990). In mammalian cells, NHEJ is the prominent pathway for 
DSBs repair and during the cell cycle it functions predominantly in G1 phase (Delacôte and 
Lopez, 2008). However, because of frequent lost of nucleotides at the break site, this pathway 
is considered to be error-prone and does not guarantee the preservation of genetic stability 
(Guirouilh-Barbat et al., 2004).  
HR is, in contrast to NHEJ, an accurate and error-free repair mechanism of DSBs. HR 
relies on the presence of an intact homologous duplex, generally sister chromatid, to template 
the repair of the broken chromosome (Pâques and Haber, 1999). Mechanism of HR will be 
discussed in more detail in the following chapter. This repair pathway requires the presence of 
homologous DNA and functions therefore preferentially during the S and G2 phase of the cell 
cycle where the sister chromatid is available (Takata et al., 1998). Products of HR are gene 
conversion associated either with or without crossing-over, a reciprocal exchange of adjacent 
sequences. Gene conversion (asymmetric transfer of genetic information) between two 
heteroalleles can result in loss of heterozygosity, or can transfer an inactivating mutation from 
one pseudo-gene to one related active gene. Excessive HR events can thus generate mutagenic 
alterations. Evidently, HR must be carefully regulated to match specific cellular needs. 
The cellular mechanism that regulates the decision between NHEJ and HR is not yet 
elucidated. Recent studies in mammalian cells suggest that tumor suppressor protein CtIP, 
which is a central regulator of DNA resection (Sartori et al., 2007), shifts the balance of DSB 
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2.2.1 Mechanism of homologous recombination 
The classical model of DSB repair by HR predicts several distinct outcomes through two main 
subpathways (Figure 2), termed “double-strand break-repair” (DSBR) and “synthesis 
dependent strand annealing” (SDSA) that have identical initial steps.  
To initiate HR, the ends of the broken DNA are resected by 5´to 3´ nucleolytic 
degradation to create an extended region of 3´ ssDNA that serves as substrate for the HR 
machinery. This step is mediated by the MRE11/RAD50/NBS1 (MRN) complex (Lamarche et 
al., 2010), which is the primary damage sensor in the cellular response to DSBs. It binds to 
DSBs to promote DNA end processing and takes part in activation of ATM , the DNA damage 
checkpoint kinase (Assenmacher and Hopfner, 2004). MRN complex also activates the CtIP 
protein, which is responsible for DNA end resection (Yun and Hiom, 2009). 
In the second step, the resulting ssDNA tail is rapidly coated by replication protein A 
(RPA), an essential eukaryotic ssDNA-binding protein. RPA is a heterotrimeric complex that 
stabilizes ssDNA regions. Next, RAD51 recombinase assembles onto the ssDNA to form a 
nucleoprotein filament (also known as nucleofilament or presynaptic filament), the catalytic 
core of HR. The resulting RAD51 nucleoprotein filament then searches for a homologous 
sequence within dsDNA and promotes the invasion of the ssDNA into the homologous dsDNA 
target to create a three-stranded DNA intermediate called displacement loop (D-loop). Both, 
RPA and RAD51 will be further described in the following chapters 2.2.2 and 2.2.3, 
respectively. 
Nucleoprotein filament assembly as well as D-loop formation are dependent on several 
recombination mediators and accessory proteins (San Filippo et al., 2008). Firstly, the 
nucleation of the RAD51 recombinase onto ssDNA is a slow process, because the RPA 
proteins compete with RAD51 for sites on the ssDNA and pose a challenge to successful 
nucleoprotein filament assembly. To overcome the inhibitory effect of bound RPA, mediator 
proteins such as BRCA1, BRCA2, the RAD51 paralogs (RAD51B, RAD51C, RAD51D, 
XRCC2 a XRCC3) and RAD52 serve to promote filament assembly. Secondly, dsDNA 
translocases such as RAD54 and RAD54B assist RAD51 in search for DNA homology and 
stimulate D-loop reaction (Heyer et al., 2006, Sugiyama and Kowalczykowski, 2002). 
In the following stage of HR, the invaded DNA strand is extended from the 3´-end by 
DNA synthesis catalyzed by DNA polymerase eta utilizing the intact DNA template 
(McIlwraith et al., 2005). 
The DSBR model predicts that the second end of the break is captured by the displaced 
strand from the D-loop and is used to prime a second round of leading strand DNA synthesis. 
The resulting DNA heteroduplex contains a double Holliday junction (dHJ) structure, the 
Current state of knowledge 
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intermediate needed to be resolved to allow the repaired DNA molecules to separate. This step 
is carried out by specialized endonucleases, so-called resolvases, that can bind to an HJ and 
introduce two symmetrically related cuts in the DNA strands at the junction. Depending on 
which pairs of DNA strand are nicked, dHJ resolution can give rise to crossover or non-
crossover products (Sung and Klein, 2006). 
During the SDSA, the invading strand that has been extended by DNA synthesis is 
displaced and anneals to the second resected DSB end. The remaining gaps can be filled by 
DNA synthesis and the nicks ligated. This subpathway forms only non-crossover products (San 
Filippo et al., 2008). 
Generation of crossovers by dHJ resolution can have stabilizing, but also destabilizing 
effects on the genome. In meiosis, crossovers are highly regulated such that at least one 
crossover occurs between each pair of homologous chromosomes, yet excess crossovers are 
suppressed (Champion and Hawley, 2002). In mitosis, crossovers pose serious risk of large-
scale genome alterations. The SDSA repair mechanism reduces the potential for genomic 
rearrangements and is therefore the predominant pathway of HR-mediated repair of DSBs 












Figure 2  Schematic model of repair of DNA double-strand breaks by homologous 
recombination. Double-strand breaks (DSBs) can be repaired by two principal homologous 
recombination (HR)-mediated subpathways, including synthesis-dependent strand annealing 
(SDSA) and classical double-strand break repair (DSBR). (a) In both pathways, repair is initiated 
by DSB resection to provide 3´ single-stranded DNA (ssDNA) overhangs, which become a 
substrate of the HR protein machinery to catalyze a search for homologous sequence in a partner 
chromosome. Strand invasion and D-loop formation are followed by DNA synthesis. (b) In the 
SDSA subpathway, the D-loop is displaced and the extended ssDNA anneals to ssDNA overhang 
on the other break end. The gaps are filled by DNA synthesis and the reaction is completed by 
ligation. The repair products of SDSA are always non-crossovers. (c) Alternatively, the second 
DSB end can be captured to form an intermediate with two Holliday junctions (HJs). After gap-
filling DNA synthesis and ligation, the structure is resolved at the HJs to give rise to non-crossover 
(black triangles) or crossover (gray triangles) products (San Filippo et al., 2008).  
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2.2.2 The Replication protein A 
The single-stranded DNA binding proteins (SSBs) are ubiquitous molecules present in all 
organisms. They bind and thus stabilize ssDNA regions. Among them, RPA is the major 
eukaryotic SSB protein. It consist of three subunits including RPA70, RPA32 and RPA14 
(Figure 3), where the numbers indicate approximate molecular weight in kDa (Wold, 1997). 
As a heterotrimer, RPA binds tightly to ssDNA via oligonucleotide binding (OB)-folds 
(Bochkareva et al., 2002). The DNA binding activity has been localized predominantly to the 
70-kDa subunit. dsDNA and RNA can also serve as binding substrate for RPA, however the 
affinity is at least three times lower than its affinity to ssDNA (Wold and Kelly, 1988).  
In the cell, RPA plays essential roles in many aspects of DNA metabolism, including 
DNA replication, DNA repair, DNA recombination, telomere maintenance and DNA damage 
signaling. In response to DNA damage, RPA becomes phosphorylated (Brush et al., 1994) by 
checkpoint kinases including ATM, ATR and DNA-PK. This modification may change the 
functions of RPA, and thus the activities of individual pathways in which it is involved (Zou et 
al., 2006).  
 
 
Figure 3  Schematic diagram of domain structure of RPA. 
Replication protein A (RPA) is heterotrimeric complex, which consists of RPA70, RPA32 and 
RPA14 subunits. Domains are presented as boxes: oligonucleotide binding (OB)-folds in blue; 
single-strand DNA binding domains A-D by hatching; winged helix domain in green; protein-
protein binding domains in red bars; site of phosphorylation by a circled P; regions of subunit 
interaction are indicated by arrows; numbers under each subunit denote the domain edge in amino 
acids (Fanning et al., 2006). 
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RPA has been found to interact specifically with various proteins. During HR, RPA has 
been shown to interact with RAD51, RAD52, BRCA1, BRCA2, p53 to modulate their 
activities (Zou et al., 2006). Although many different proteins interact with RPA, the RPA70 
seems to be the main subunit responsible for protein interactions. There is evidence that 
RPA32 also participates in protein-protein interactions via C-terminal winged helix domain 
(Wold, 1997). RPA32 becomes phosphorylated at its N-terminus in a cell-cycle dependent 
manner and in response to DNA damage (Liu and Weaver, 1993, Treuner et al., 1999). RPA70 
alone cannot fulfill its proper function, demonstrating that the 32-kDa and 14-kDa subunits of 
RPA are essential. 
Depending on the circumstances, RPA can exert a stimulatory or an inhibitory effect on 
the nucleoprotein filament formation. RPA may facilitate filament assembly via removal of 
possible secondary structure present on the ssDNA (Eggler et al., 2002). On the other hand, 
RPA poses a hurdle for an efficient RAD51 polymerization on the ssDNA (Fanning et al., 
2006).  
 
2.2.3 The RAD51 recombinase 
The catalytic core of the HR machinery is composed of proteins belonging to the RecA/Rad51 
family of recombinases that assemble into nucleoprotein filament on ssDNA to promote 
pairing of homologous DNA molecules and strand exchange. In most eukaryotes, two 
orthologs of Escherichia coli (E. coli) recombinase RecA are present: RAD51 and DMC1 
(Figure 4). Both have the unique ability to search for homologous sequence and to catalyze the 
exchange of DNA strands. Whereas RAD51 is ubiquitously expressed, DMC1 expression is 
restricted only to meiosis. In higher eukaryotes, RAD51 is essential, as indicated by the 
embryonic lethality associated with RAD51 deletion from the mouse genome (Lim and Hasty, 








Figure 4  The RecA/RAD51 family of recombinases. 
Schematic illustration of Escherichia coli (E. coli) RecA, human RAD51 and human DMC1 
proteins. Domains and regions are represented as boxes of different colors according to the key at 
the bottom of the figure (Thorslund and West, 2007). 
 
 The human RAD51 recombinase is relatively small protein of about 37 kDa and shares 
with other members of family a large core domain containing the Walker A and B motifs 
responsible for binding and hydrolysis of ATP. RAD51 exists as homo-oligomer and, in 
solution, forms heptameric ring structure (Figure 5) (Shin et al., 2003). RAD51 binds to both, 
dsDNA and ssDNA, but its preferred substrate is dsDNA with ssDNA overhangs (Mazin et al., 
2000). On ssDNA, RAD51 polymerases to create a highly ordered, right-handed helical 
nucleoprotein filament, the catalytically active form (Ogawa et al., 1993). The nucleoprotein 
filament is capable to hold three DNA strands, a ssDNA and a homologous double helix, to 
allow them to test the complementarities and exchange strands if a match is found (Sinha and 
Peterson, 2008).  
 Binding of ATP to the Walker motif A is an important prerequisite for catalytically 
competent RAD51 filament activity. ATP hydrolysis is linked to dynamic disassembly of the 
filament (Ristic et al., 2005). The fast turnover of the RAD51 filament is thought to generate 
an intracellular pool of free RAD51 proteins available for HR and DNA repair reactions (Chi 
et al., 2006).  




Figure 5  Illustration of RAD51 structure and nucleoprotein filament.  
a) In solution, RAD51 forms heptameric ring structures (left), whereas in the presence of single-
strand DNA (ssDNA), RAD51 monomers assemble into a highly ordered right-handed 
nucleoprotein filament (right), as indicated schematically and by electron microscope visualization 
(Shin et al., 2003, Thorslund and West, 2007). b) The nucleoprotein filament on triplex DNA. 




2.2.4 Regulation of homologous recombination 
Recombinational DNA repair is not constitutive but is tightly controlled by positive 
and predominantly negative regulatory mechanisms (Heyer et al., 2010). There are many 
stages where HR can be regulated. The most salient regulatory stages represent: 3´ ssDNA 
resection, nucleoprotein filament assembly, D-loop structure formation and dHJ resolution. A 
class of enzymes known as recombinases and large spectrum of other specialized proteins have 
been involved in the proper modulation of certain steps in HR (Holthausen et al., 2010). In the 
following part, I will focus only on the regulation of nucleoprotein filament assembly in more 
details. 
 
2.2.5 Regulation of nucleoprotein filament assembly 
The nucleoprotein filament poses an ingenious checkpoint for HR regulation. The efficiency of 
HR is enhanced by mediator proteins, such as Rad52 in yeast (Sugiyama and Kowalczykowski, 
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2002), that promote the loading of Rad51 onto ssDNA. On the other hand, specialized DNA 
helicases (DNA helicases are described in following chapter) have the ability to translocate 
along the ssDNA and remove RAD51 from the nucleoprotein filament. Specifically, Srs2 
helicase (described in chapter 2.3.3) in yeast and RECQ5 helicase (described in chapter 2.3.5) 
in mammals have been shown to harbour this competency (Colavito et al., 2010). Through this 
action, these helicases efficiently prevent undesirable HR events.  
 
2.3 DNA helicases 
Helicases are ubiquitous enzymes with nucleic acid-dependent NTPase activity to move along 
the DNA and catalyze breaking of hydrogen bonds that hold the DNA strands together. 
Although DNA helicases were discovered on the bases of the ability to catalyze separation of 
the complementary strands of dsDNA during replication, recombination and DNA repair, it is 
now evident that this class of enzymes also functions in a range of other biological processes, 
including displacement of proteins from DNA, remodeling of chromatin, movement of HJs, 
and the catalysis of various of nucleic acid conformational changes (Tuteja and Tuteja, 2004). 
Recently, it has become clear that several putative helicases use NTP to translocate with biased 
directionality along ss- or dsDNA, they are so-called translocases. Selected few 
helicases/translocases endowed with the ability of displacement of proteins from either ss- or 
dsDNA (Lohman et al., 2008, Singleton et al., 2007). Therefore, it is not surprising that most 
organisms encode multiple helicases, for example, E. coli has at least 12 and humans even 24 
different helicases (Tuteja and Tuteja, 2004). 
Studies over the last decades have identified a variety of helicases that differ in both 
structure and mechanism of reaction. Helicases have been classified into six superfamilies 
(SF), SF1-SF6, based on the presence and organization of short conserved amino acid (aa) 
sequences (Q, I, Ia, Ib, II, III, IV, V and VI), called helicase motifs (Singleton et al., 2007). 
DNA helicases move along the DNA with a processivity and directionality, i.e. 3´ to 5´ or 5´ to 
3´, specific to each particular enzyme. Some of them are active as monomers, some of them as 
oligomers (Singleton et al., 2007).  
The well known ring-shaped hexameric helicases, which encircle the nucleic acid and 
move usually in the 5´ to 3´ direction, function mainly, but not exclusively, as the primary 
helicases in DNA replication. However the majority of helicases/translocases is non-hexameric 
and belongs to SF1 and SF2. The two largest SFs, SF1 (Figure 6) and SF2, contain at least 
seven conserved helicase motifs (I, Ia, II-VI) in their primary structure. Motifs I and II are 
equivalent to the classical Walker A (phosphate-binding loop) and Walker B (Mg2+-binding 
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site) motifs found in ATPases, respectively (Walker et al., 1982). Well-characterized members 
of SF1 are the bacterial helicases Rep, PcrA, UvrD and the Saccharomyces cerevisiae (S. 
cerevisiae) Srs2. Intensively studied members belonging to SF2 are, for example RecQ family 
helicases.  
The importance of DNA helicases is underscored by the numerous human diseases 
such as Werner syndrome, Bloom syndrome, Rothmund-Thomson syndrome or Xeroderma 





Figure 6  Domain structure of Superfamily 1 helicases/translocases. 
a) Superfamily 1 (SF1) of helicases/translocases contains seven conserved helicase motifs (I, Ia, II-
IV). The protein structure of these helicases is divided into two domains (1 and 2) that are further 
organized into two subdomains (1A and 1B; 2A and 2B). b) Modular model of folding of the 






DNA helicases control HR pathways at several stages and affect HR in both a positive and a 
negative manner. So-called prorecombinases are believed to positively modulate HR to 
promote the repair process. As antirecombinases are collectively termed DNA 
helicases/translocases, which negatively regulate HR pathway, thus, suppress crossovers 
production (Wu and Hickson, 2006). Helicases with antirecombinase function are conserved 
from bacteria to human.  
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In the following sections, I will emphasize several important enzymes, which were 
shown to exert antirecombinase activity, involving UvrD, Srs2, BLM, RECQ5, and RTEL1. 
FBH1, the subject of this thesis is described in more detail in chapter 2.4. 
 
2.3.2 The bacterial UvrD helicase 
Bacterial UvrD is the founding member of SF1 helicases. It translocases along ssDNA in the 3´ 
to 5´ direction (Matson and George, 1987). UvrD can act as monomers or dimers. Beside its 
critical role in replication, repair of mismatched base pairs, UvrD possesses antirecombinase 
activity by dismantling RecA (the bacterial RAD51 ortholog) nucleoprotein filament and 
inhibits RecA-mediated strand-exchange reaction in vitro (Veaute et al., 2005).  
 
2.3.3 The yeast Srs2 helicase 
Srs2 helicase, a central player in regulation of HR in S. cerevisiae and S. pombe (Wang et al., 
2001), is the best understood eukaryotic antirecombinase. It belongs to the SF1 helicase family 
and is structurally and functionally related to the UvrD helicase (Colavito et al., 2009). 
Experimental data showed that Srs2 restricts inappropriate recombination events by Rad51 
nucleoprotein filament disassembly (Krejci et al., 2003, Veaute et al., 2003). Mutations in the 
SRS2 gene exert elevated level of crossover products after DNA damage (Chanet et al., 1996). 
Additionally, further experiments suggest that Srs2 promotes DSB repair by SDSA pathway to 
generate harmless non-crossover products (Dupaigne et al., 2008). Although Srs2 is conserved 
in budding and fission yeast, no direct Srs2 homolog have been found in higher eukaryotes.  
 
2.3.4 The human BLM helicase 
BLM belongs to a highly conserved RecQ family of helicases. This whole group of proteins is 
actively involved in genome surveillance. Beside BLM helicase, RecQ family includes five 
members (Figure 7), namely RECQ1, WRN, RECQ4 and RECQ5, in humans. What makes 
RecQ helicases subject of intense research is their implication in human diseases. Loss of 
function of three of the five RecQ family genes (BLM, WRN and RECQ4) has been shown to 
give rise to inheritable disorders Bloom´s, Werner´s and Rothmund-Thomson´s syndrome, 
respectively, associated with genomic instability, cancer predisposition, developmental 
abnormalities and premature aging (Hanada and Hickson, 2007). 
 
 




Figure 7  The human RecQ family of helicases. 
Members of humans RecQ family, BLM, WRN, RECQ4, RECQ1 and RECQ5β are shown. 
Proteins are aligned by the conserved helicase domain, which is shown as a light blue box. The 
additional domains included are illustrated as follows: RecQ carboxy-terminal (RQC) by red box; 
Helicase and RNase D C-terminal (HRDC) by yellow box; exonuclease (Exo) domain in green 
box; and Sld2-like domain is depicted in orange. Here, only the largest isoform of RECQ5, 




Bloom helicase (BLM) is named after Bloom´s syndrome, a rare autosomal recessive 
disorder caused by mutation in its gene. Patients with this syndrome are predisposed to 
development of most types of cancer (Hickson, 2003). Among the human RECQ helicases, 
BLM has the unique property to display a broad spectrum of activities that exert both pro- and 
anti-recombinase character at different stages (Bugreev et al., 2007). In the early phase of HR, 
BLM can prevent premature initiation of recombination events by disrupting RAD51 
nucleoprotein filament. On the other hand, it may also stimulate recombination by co-operation 
with exonuclease EXO1 to resect one strand of the broken DNA to generate 3´ ssDNA 
overhangs. Recent studies also showed that BLM is active at later stages of HR, where it may 
catalyze the D-loop dissociation to push the repair process to non-crossover SDSA pathway 
(Bugreev et al., 2007, van Brabant et al., 2000, Wu and Hickson, 2003). 
 
2.3.5 The RecQ5 helicase 
The human RECQ5 protein is another representative of RecQ family helicases. It exists in 3 
different isoforms resulting from alternative splicing of the RECQ5 transcript. The variants are 
RECQ5α, RECQ5β (here referred to RECQ5) and RECQ5γ (Sekelsky et al., 1999, Shimamoto 
et al., 2000). Only the largest form RECQ5 possesses the zinc-finding motif (a region 
responsible for DNA binding), exhibits ATP-dependent 3´ to 5´ helicase activity and localizes 
in nucleus (Garcia et al., 2004). Recent data indicate that RECQ5 physically interacts with 
RAD51 and has the capability to disrupt nucleoprotein filament (Hu et al., 2007, Schwendener 
et al., 2010). At present, no genetic disease has been associated with RECQ5 dysfunction. 
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Nevertheless, RECQ5 deficiency in mice is associated with cancer susceptibility, suggesting 
that RECQ5 acts as a tumor suppressor (Hu et al., 2007).  
 
2.3.6 The RTEL1 helicase 
Recent studies have revealed that RTEL1, the regulator of telomere elongation helicase 1, is 
one of the putative Srs2 functional homolog. It plays an essential role in genome and telomere 
length maintenance. After DNA damage, RTEL1 is recruited to DSB, where it acts as 
antirecombinase by D-loop disassembly to promote harmless SDSA repair subpathway. 
Dysfunction of RTEL1 is linked to glioma predisposition (Ding et al., 2004, Barber et al., 
2008, Uringa et al., 2011).  
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2.4 The F-box DNA helicase 1 
F-box DNA helicase I (Fbh1; also known as FBXO18 according the Human Genome 
Organization Gene Nomenclature Committee) was first isolated by Park and colleagues from 
S. pombe as a DNA helicase I (Park et al., 1997). Its human homolog, FBH1, has been 
identified by the same group few years later (Kim et al., 2002). Further biochemical and 
bioinformatic screening revealed that FBH1 harbors 7 conserved helicase motifs at the C-
terminus and belongs to UvrD class of SF1 family of helicases. Currently, there are 4 isoforms 
of FBH1 that vary in the N-terminal part (Internet source 1). The longest version of FBH1 with 
1094 aa, isoform 1, isoform 2 that has 1043 aa, isoform 3 with 986 aa, and the shortest, 
isoform 4 spanning 969 aa (Figure 8). Homologs of the human FBH1 have been found in 
mammals, birds and S. pombe. However, FBH1 is absent in organisms such as fish, frog, fruit 
fly, plants and S. cerevisiae (Chiolo et al., 2007, Kim et al., 2002, Park et al., 1997, Osman et 
al., 2005). As a DNA helicase, FBH1 posses ATPase activity and translocates in the 3´ to 5´ 
direction preferentially on ssDNA (Kim et al., 2002). 
Interestingly, beside the helicase domain FBH1 is endowed by presence of highly 
conserved F-box motif at the N-terminal part (Kim et al., 2002). This is a feature, which makes 
FBH1 unique among all DNA helicases.  
 
 
Figure 8  A schematic outline of FBH1 isoforms. 
Four FBH1 isoforms are shown. The F-box motif is shown as violet box and the helicase domain as 
red box. The numbers on the right denote length of each protein in amino acids (aa).  
 
 
2.4.1 FBH1 as a member of SCF complex 
The presence of the F-box motif allows FBH1 to act as an F-box protein, which is the 
interchangeable element of multisubunit enzyme, the SCF complex (named after the main 
components, Skp1, Cullin, and an F-box protein) (Figure 9). When established, the SCF 
complex functions as an E3 ubiquitin ligase, which specifically targets substrates for 
degradation in proteasome.  
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The SCF complex is a multiprotein enzyme composed of an invariant core containing three 
basic components: 
 Skp1 is an adaptor protein, which is responsible for recognition and binding of F-box 
proteins via the F-box motif. 
 Cullin functions as a scaffold element of the complex to link the Skp1 protein with 
Rbx1 protein. 
 Rbx1 protein possesses a RING finger domain and mediates binding to the E2 
(ubiquitin-conjugating) enzyme. 
 
The substrate specificity of the SCF complex is dictated by the interchangeable F-box 
protein that recruits specific set of proteins for ubiquitination and proteosomal degradation. In 
general, phosphorylation of the target substrate is a common prerequisite for recognition by 
individual F-box protein. The ability of the Skp1 protein to bind to multiple F-box proteins 
with distinct substrate specificities substantially increases the target protein repertoire (Bai et 
al., 1996, Cardozo and Pagano, 2004). 
 
 
Figure 9  A schematic model of SCF complex. 
The core of the SCF (Skp1-Cullin-F-box) complex constitutes of four major compounds: F-box 
protein (FBP) containing F-box motif, adaptor protein Skp1, scaffold protein Cullin and Rbx1. E2, 
ubiquitin-conjugating enzyme; Ub, ubiquitin. 
 
 
2.4.2 FBH1 as an F-box protein 
The F-box motif, approximately 50 aa long region (Figure 10), is a protein-protein interaction 
site, generally present at the N-terminal half of a protein. The name is derived from its 
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occurrence in cyclin F, the first protein in which this motif was identified (Bai et al., 1996). F-
box proteins constitute a large family in eukaryotic kingdom. For instance, 69 representatives 
of the F-box protein family have been identified in human to date (Internet source 2), ~20 in 
yeast species (Skaar et al., 2009), ~30 in Drosophila melanogaster (Ou et al., 2003), ~520 in 





Figure 10  A consensus sequence of F-box motif. 
The single-letter amino acid code is used. The most prevalent residues at each position within the 
alignment are shown as bold and underlined capital letters. Similar residues are represented as bold 
and non-underlined capital letters. Amino acids exhibiting less than 20% overall similarity are 
signified as bold lower case letters and the residues found in 10-14% of the F-box sequences are 
shown as non-bold lower case letters. The consensus was generated from alignment of 234 





F-box proteins are sorted out into three major groups based on the type of substrate 
interaction domain identified in addition to the F-box motif. The two most common of which 
are leucine-rich repeats, FBXL, and WD40 domain, FBXW group. In the third group of F-box 
proteins, FBXO, various other type of domain is present or absent at all (Jin et al., 2004). 
FBH1 protein falls into the last group of F-box proteins, FBXO (Figure 11), and moreover, 
FBH1 is the only example of the F-box protein family that retains intrinsic enzymatic activity.  
 Not only FBH1 alone, but also bound to the SCF complex (SCFFBH1) retains ATPase 
activity and can act as DNA helicase to translocate along the ssDNA (Kim et al., 2004). The 
multiple activities present in the SCFFBH1 complex are independent of each other, so that the 










Figure 11  Domain organization of representative F-box proteins. 
The family of mammalian F-box proteins is grouped into three classes, FBXW, FBXL and FBXO. 
FBXW includes proteins with an F-box (F) and WD40 (W) repeats; FBXL includes proteins with 
an F-box and leucine-rich repeats (L); and FBXO denotes proteins with an F-box and either another 
or no other motifs. The other less common protein motifs are: transmembrane domain (T); F-box 
associated domain (FBA); between-ring domain (IBR); domain in carbohydrate binding proteins 
and sugar hydrolases (CASH); kelch repaet (K); calponin homology domain (CH); domain found 
in cupin metalloenzyme family (Jmjc); domain present in PSD-95, Dlg, and ZO-1 (PDZ); zinc-
binding domain found in Lin-11, Isl-1, and Mec-3 (Lim); HNH nuclease family (HNHc); novel 
eukaryotic zinc-binding domain (CHORD); tetratrico peptide repeat (TPR); ApaG-like domain 
(ApaG-like); ubiquitin-like fold (UBL); Traf-domain like (TDL); Apolipophorin; RNI-like; and 
RCC1. FBH1 (FBXO18), highlighted by the red box, is the only F-box protein containing 
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Beside its role in the SCF complex, the F-box motif is further required for both the 
recruitment of FBH1 to nucleus and DNA damage-induced foci formation (Sakaguchi et al., 
2008, Kim et al., 2004), showing that the F-box motif, the element responsible for binding of 
Skp1, is necessary for the proper catalytic function of FBH1. 
 At present, target substrate of SCFFBH1 complex has not been identified. Recent 
experiments in S. pombe revealed one potential ubiquitination target recognized by Fbh1, 
however without any known role during DNA repair. It is a transcription factor Atf1, which 
plays a vital role in stress-induced response in S. pombe (Lawrence et al., 2009, Lawrence et 
al., 2007). In absence of stress, Atf1 is basally phosphorylated, recognized by Fbh1 and 
targeted for degradation. Upon the stress exposure, Atf1 becomes hyper-phosphorylated and no 
recognition occurs (Lawrence et al., 2009). Since the most of F-box protein–substrate 
interactions are mediated positively by phosphorylation, this kind of recognition is very 
untypical among the F-box protein family. 
 
2.4.3 Role of FBH1 as DNA helicase 
In DNA metabolism, FBH1 is believed to be another member of the group of proteins that 
control recombination (Osman et al., 2005). The helicase domain of FBH1 is structurally very 
similar to those present in Srs2 and UvrD (Figure 12). In order to gain more insight into the 
FBH1 function in the cell, the FBH1 protein has been studied in yeast and human cells. Human 
FBH1 seems to be a functional homolog of Srs2 in S. cerevisiae (Chiolo et al., 2007). Similar 
to Srs2, FBH1 accumulates at sites of DNA damage and appears to play a role in controlling 
Rad51 activity (Morishita et al., 2005, Fugger et al., 2009). Evidence for this comes from 
observation in both S. pombe and humans showing that levels of DNA damage-induced 
RAD51 foci are reduced in cells over-expressing FBH1, whereas spontaneous RAD51 foci 
increase in FBH1 deficient cells (Morishita et al., 2005, Lorenz et al., 2009, Fugger et al., 
2009). Another experiments revealed, that FBH1 is a competitor of Rad22, one of the mediator 
proteins responsible for Rad51 nucleation in S. pombe (Osman et al., 2005). The failure to 
restrict RAD51 nucleoprotein filament formation in S. pombe Fbh1 deficient cells results in 
elevated levels of sister chromatid exchange (SCE), which can lead to genomic instability 
(Kohzaki et al., 2007). The exact mechanism, how FBH1 controls RAD51 is currently not 
known, however it appears to be dependent on its DNA helicase/translocase activity 
(Sakaguchi et al., 2008, Lorenz et al., 2009). Fugger and colleagues moreover suggest FBH1 to 
retain prorecombinase activity at sites of replication block (Fugger et al., 2009).  
 




Figure 12  Amino acid sequence alignment of helicase domains present in UvrD-like helicases. 
Helicases are aligned by the seven helicase motifs (I, Ia, II-IV) found in: Escherichia coli (ec) 
UvrD; Saccharomyces cerevisiae (sc) Srs2; Schizosaccharomyces pombe (sp) Srs2; 
Schizosaccharomyces pombe Fbh1; mouse (m) Fbox18; and human FBH1. Identical and conserved 
amino acids are indicated by gray and white boxes, respectively. The numbers between individual 
helicase motifs represent the location in amino acids of each motif within its parent protein (Chiolo 




2.4.4 Role of FBH1 in meiosis and chromosome segregation 
Interestingly, very recent studies have shown that FBH1 plays an additional role during 
meiosis. According to experiments in S. pombe and mouse embryonic stem cells, Fbh1 and 
FBH1 appear to be essential for proper chromosome segregation (Sun et al., 2011, Okamoto et 
al., 2012, Laulier et al., 2010). Exactly how a failure of Fbh1 function can cause abnormal 
chromosome segregation is uncertain. 
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3 Aims of the work 
 
FBH1 DNA helicase is implicated in regulation of homologous recombination. It has been 
suggested to exert its antirecombinase function through disruption of RAD51 
nucleoprotein filaments. However, this proposal has never been tested experimentally. To 
understand the mechanism of how FBH1 controls RAD51 action, we pursued the 
following experiments: 
 
1. Preparation of chicken polyclonal antibody against N-terminal fragment of human 
FBH1. 
2. Expression and purification of the wild type and ATPase-dead forms of the human 
FBH1 protein, and examination of their enzymatic activities. 
3. Investigation of the interaction of human FBH1 with RPA and RAD51.  
4. Test the ability of human FBH1 to disrupt RAD51 nucleoprotein filament. 
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4 Material and methods 
4.1 Chemicals 
Chemicals used:     Company: 
25- and 35-oligonucleotide     Microsynth 
53- and 93-oligonucleotide     IDT 
Acetic adic       Penta 
Acrylamide solution     Serva 
Agarose       Serva 
Ammonium persulphate     Serva 
ATP       Fermentas 
Bestatin       Biochemica 
Boric acid       Penta 
Bradford reagent      Biorad 
Bromophenol blue     Lachema 
BSA        Sigma-Aldrich 
Calf intestine alkalic phosphatase    Fermentas 
Cellfectin II      Invitrogen 
Chitin beads       BioLabs 
Coomassie Brilliant Blue R250   Sigma-Aldrich 
Creatine phosphate     Sigma-Aldrich 
Creatine phosphokinase     Sigma-Aldrich 
Dithiotreitol      Sigma-Aldrich 
DMEM medium     Sigma-Aldrich 
dNTPs       Fermentas 
ECL western blot substrate     Thermo Pierce 
EDTA        Applichem 
Ethanol       Penta 
Ethanolamine      Sigma-Aldrich 
Ethidium bromide     Biorad 
Fetal bovine serum     Gibco 
Formaldehyde      Penta 
Glucose       Applichem 
Glutathione agarose      Macherey-Nagel 
Glutathione      Applichem 
Glycerol       Lachner 
Glycine       Applichem 
Grace´s Insect Cell Culture Medium    Sigma-Aldrich  
Heparin beads      GE Healthcare 
HCl       Penta 
IPTG        Fermentas 
Isopropanol       Lachner 
K2HPO4       Sigma-Aldrich 
KCl       Lachema 
Material and methods 
32 
 
Lactalbumin hydrolysate     Applichem 
LB Miller Broth powder     Sigma-Aldrich 
Leupeptin       Applichem 
Ligation buffer     Fermentas 
Lipofectamine RNAiMAX     Invitrogen 
Malachite green      Sigma-Aldrich 
Methanol       Penta 
MgCl2       Sigma-Aldrich 
MgSO4       Sigma-Aldrich 
Na2CO3      Penta    
NaCl        Lachner 
NaF       Applichem 
NaHCO3      Serva 
Natrium orthovanadate     Applichem 
(NH4)6Mo7O24      Sigma-Aldrich 
NHS-activated agarose column   GE Healthcare 
Nonidet P-40       Applichem 
NTP        Fermentas 
Opti-MEM      Invitrogen 
PEG 2000       Serva 
PEG 6000       Fluka 
Pepstatin A      Applichem 
Pfu polymerase     Fermentas 
Pluronic F68      Sigma-Aldrich 
PMSF       Applichem 
Ponceau S      Sigma-Aldrich 
Protease inhibitor cocktail     Roche 
Protein A/G PLUS-Agarose     Santa Cruz 
Proteinase K      Roche 
RNase A       Applichem 
Silver nitrate       Safina Vestec 
Sodium acetate     Sigma-Aldrich 
Sodium citrate      Fluka   
Sodium dodecyl sulphate    Applichem 
Sodium pyrophosphate    Fluka 
Sodium thiosulphate      Lachema 
SuperSignal® West Dura     Thermo Pierce 
SuperSignal® West Femto     Thermo SCIENTIFIC 
T4 ligase       Fermentas 
Tango buffer       Fermentas 
TEMED       Applichem 
Topoisomerase I      Invitrogen 
Tris(hydroxymethyl)-aminomethane (Tris)   Applichem 
Triton X-100       Applichem 
Tween-20       Sigma-Aldrich 
X-gal       Fermentas 
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Yeastolate      Applichem 
β-mercaptoethanol      Applichem 
 
Kits 
DNA fragments were isolated using NucleoSpin® Extract II Kit (Macherey-Nagel) from 
agarose gel. Plasmids were purified using NucleoSpin® Plasmid purification Kit (Macherey-
Nagel). 
QuantiProTM BCA Assay Kit (Sigma-Aldrich) and Quick StartTM Bradford Protein Assay (Bio-
Rad Laboratories) were used for determination of protein concentration. 
 
Protein markers 
PageRuler™ Plus Prestained Protein Ladder (Thermo SCIENCE) 
PageRuler™ Unstained Protein Ladder (Thermo SCIENCE) 
HMW-SDS Marker Kit (GE Healthcare) 
LMW-SDS Marker Kit (GE Healthcare) 
   
4.2 Antibiotics 
Used antibiotics:    Concentration:  Company: 
Ampicillin      100 μg/ml  Applichem 
Gentamicin     7 μg/ml  Lek Pharmaceutical 
Kanamycin     50 μg/ml  FisherBiotech 
Penicillin/Streptomycin solution   100 U/100 μg/ml Sigma 
Tetracycline     10 μg/ml  Sigma 
 
4.3 Technical equipment 
Technical equipment used:    Company: 
Analytical balance BBI-32     BOECO 
Balance       BEL engineering 
Bioruptor TM Next gen     Diagenode 
Centrifuge 5415R      Eppendorf 
Centrifuge 5810R      Eppendorf 
Centrifuge ROTANTA 460R     Hettrich 
Centrifuge J2-21M      Beckman 
Centrifuge NF 400      Nüve 
Centrifuge Spectrafuge 24D     Labnet 
CO2 Incubator       Thermo SCIENTIFIC 
X-ray film processor Optimax 2010   Protec 
Electroblotter Hep-1      Thermo SCIENTIFIC 
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Electroblotter HorizBlot AE-6675L   ATTO 
Flow box Bio-II-A      Teslar 
Ice flaker       Brema 
Incubator EN-120      Nüve 
Light Microscope Eclipse TS100    Nicon 
Magnetic stirrer CB161     Stuart 
Magnetic stirrer MSH-300     Biosan 
Memmert incubator INE 400     LAB system 
PCR cycler Biometra TPersonal    LABRepCo 
PCR cycler MJ Mini Gradient    Biorad 
pH meter W3B      BEL engeneering 
Power supply EDURO     Labnet 
Power supply PS304      APELEX 
Rocker 25       Labnet 
Roller SRT6       Stuart 
Rotator Bio RS-24      Biosan 
Shaking incubator 311DS     Labnet 
Shaking incubator S16R-HS     SHEL LAB 
Sonicator soniprep 150     Schoeller 
Spectrophotometer MULTISCAN* EX   Thermo SCIENTIFIC 
Spectrophotometer ND-1000     NanoDrop 
Spectrophotometer S-30     BOECO 
Thermo shaker NB-205     N-Biotek 
Thermoblock HB-102      Labolan 
Thermoblock QBD2      Grant 
Water bath JB Aqua 12     Grant 
 
4.4 Cells  
Escherichia coli: 
For general cloning purposes, strain Top10 genotype: F- mcrA Δ(mrr-hsdRMS-mcrBC) 
φ80lacZΔM15 ΔlacX74 nupG recA1 araD139 Δ(ara-leu)7697 galE15 galK16 rpsL(StrR) 
endA1 λ- was used. Strains XA90 (genotype: [F' LacIQ1 Z+Y+ proAB+ Δ(lac-pro)XIII ara
- nalA- 
argE- am thi- rifR]) and BL21genotype: fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS λ DE3 = λ 
sBamHIo ∆EcoRI-B int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5 were used for protein 
expression. For bacmid production DH10Bac strain was used genotype: F- endA1 recA1 galU 
galK deoR nupG rpsL ΔlacX74 Φ80lacZΔM15 araD139 Δ(ara,leu) 7697 mrcA Δ(mrr-
hsdRMS-mrcBC). 
 




HeLa cell line was derived from cervical cancer. 
U2OS cell line was derived from an osteosarcoma. 
HEK293 cell line was generated by transformation of human embryonic kidney cells. 
 
Insect: 
Sf9 cell line was derived from pupal ovarian tissue of Spodoptera frugiperda. 
 
4.5 Plasmids 
pAS2-1-FBH1(1-969 aa) was a kind gift from Giordano Liberi, Italy. 
pTYB12-FBH1(1-484 aa) was prepared for antigen production in E. coli. 
pEGFP-N2-FBH1(1-969 aa) and pFastBac-streptavidin-FBH1(1-969 aa)-His6x were prepared 
by Igor Chevelev, Ph.D. 
pFastBac-GST-FBH1(1-969 aa)-His6x and pFastBac-GST-FBH1D698N(1-969 aa)-His6x were 
prepared for FBH1 and FBH1D698N, respectively, production in Sf9 cells.  




Primers used for antigen production:       RE:      Ann.temp: 
F 5´- catg gct agc atg gcc aaa agc aat tct gtt g -3´  Nhe I  60°C 
R 5´- gca ctc gag ttc ggc ctg ctt tgc gat -3´  Xho I  62°C 
 
Highlighted sequences denote restriction sites of restriction enzymes (RE) listed in the middle. 
Annealing temperature of each primer is shown on the right. All used primers were synthesized 
by Microsynth. All used REs were produced by Fermentas.  
 
4.7 siRNA 
siFBH1 5’-GAUACAGAGUGAAGAAUGUdTdT-3’ (Microsynth) 
siLuciferase 5’-CGUACGCGGAAUACUUCGAdTdT-3’ (Microsynth) 
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4.8 Recombinant proteins 
FBH1 antigen (1-484 aa) used for immunization, RPA, GST, RAD51K133R and Taq polymerase 
were produced and purified by Igor Chevelev, Ph.D. from bacteria.  
RECQ5β was produced and purified by Ing. Václav Urban from bacteria.  
FBH1 antigen (1-484 aa) used for anti-FBH1 antibody purification, GST-FBH1(1-969 aa)-




Used primary antibodies: 
Chicken polyclonal anti-FBH1 (purification is described in this thesis)  
Mouse monoclonal anti-FBH1 (Santa Cruz catalogue number SC-81563) 
Rabbit polyclonal anti-RAD51 (produced and purified by Igor Chevelev, Ph.D.) 
Rabbit control IgG (purified by Ing. Václav Urban) 
Rabbit polyclonal anti-GST (produced and purified by Igor Chevelev, Ph.D.) 
 
Used HRP conjugated secondary antibodies:  
Rabbit anti-chicken IgY (Sigma-Aldrich) 
Goat anti-rabbit IgG (Sigma-Aldrich) 
Rabbit anti-mouse IgG (Sigma-Aldrich) 
 
4.10 Agarose gel electrophoresis 
Agarose gel electrophoresis is a method used to separate nucleic acids; DNA or RNA 
molecules by size and structure. This is achieved by moving negatively charged nucleic acid 
molecules through an agarose matrix in an electric field (electrophoresis). The negative charge 
of the molecules is due to the phosphate backbone they possess. The separated DNA fragments 
are stained with ethidium bromide for visualization by UV-light. The size of the DNA 
fragments can be determined by comparing them to DNA-ladders with fragments of known 
size. 
In order to determine the quality of DNA, the samples such as PCR products, products 
of restriction digestion or plasmid purification, were separated by electrophoresis in 1% 
agarose gel. DNA samples were mixed with 1×DNA loading buffer containing 0.5 μg/ml of 
ethidium bromide. The gels were prepared in 1×TAE buffer containing 0.5 μg/ml of ethidium 
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bromide and the samples were mixed with 2×DNA loading buffer. The electrophoresis was 
performed in 1×TAE buffer at 80 V and gels were observed using a UV transilluminator.  
 
 
DNA loading buffer (10×) 0.25% (w/v) Bromophenol Blue; 50 mM Tris-HCl, pH 7.6;  
60% glycerol 
TAE buffer (10×)  0.4 M Tris-HCl, pH 8.0; 0.25 M acetic acid; 10 mM EDTA 
 
4.11 Cloning methods 
4.11.1 Polymerase chain reaction  
Polymerase chain reaction (PCR) is a method for enzymatic amplification of specific 
sequences of DNA. The PCR reaction goes through three different steps defined by the critical 
aspects of time and temperature; denaturation, annealing and elongation. These steps make up 
a cycle that is repeated 20-35 times to achieve a satisfying amount of amplified DNA. In the 
denaturation step, the PCR reaction is heated to a temperature of around 95 °C where the 
hydrogen bonds of the double helix are broken resulting in single-stranded molecules to be 
used as templates. In the annealing step, the reaction temperature is lowered to around 50-60°C 
so that the primers can anneal to the single-stranded DNA template forming short segments of 
double-stranded DNA where the polymerase attaches and begins DNA synthesis. During the 
extension/elongation step, the DNA polymerase synthesizes new DNA strands complementary 
to the DNA template strands. 
 
 The standard PCR mixture was prepared as follows: 
Component    Volume (µl) 
Pfu/Taq DNA polymerase (0.8 U)  1.0 
Primers F+R       2.0 
PCR buffer 10x      2.5 
dNTPs (1.3 mM)      2.5 
plasmid DNA        2.0 
H2O to final-volume    25.0 
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PCR reaction conditions: 
Phase  Temperature  Time 
Initial   94°C  3 min 
Denaturation  94°C  30 s 
Annealing    30 s 
Elongation  72°C  30 s 
72°C    5 min 
Cooling    4°C  >10 h 
Annealing temperatures of individual primers are listed in chapter 4.1.6. 
 
PCR buffer (10×) 200 mM Tris-HCl, pH 8.5; 100 mM (NH4)2SO4; 100 mM KCl;  
20 mM MgSO4 
  
4.11.2 Restriction digestion 
To prepare fitting sites for ligation, plasmid vector and insert DNA were digested (in separate 
tubes) with appropriate pair of restriction enzymes (RE). DNA digest reactions were carried 
out by overnight incubation of the following mixture at RT. 
 
Component        Quantity 
Tango buffer 10x  3.6 μl 
RE1    1.0 μl 
RE2    1.0 μl 
DNA    ~2 μg 
H2O to final-volume           36.0 μl 
 
Reaction mixture was then separated by agarose electrophoresis and digested fragments 
were purified using NucleoSpin® Extract II Kit.  
 
4.11.3 DNA ligation 
Ligation is the process in which an insert is ligated into a vector. The enzyme used to ligate 
DNA fragments is called T4 DNA ligase from bacteriophage T4.  
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   Component   Volume (μl) 
   Ligation buffer 10x   2 
   T4 ligase    1 
   Molar ratio of insert:vector  3:1 
   H2O to final-volume   20 
 
To do a self-ligation test, a control reaction containing all the reagents listed above 
except the DNA insert was set up. 
To increase ligation efficiency by preventing of self-ligation of plasmid vectors in 
ligation reaction, the terminal 5’-phosphate groups may be removed using alkalic phosphatase. 
This dephosphorylation reaction will thus decrease the number of “empty” vectors. 1 μl of calf 
intestine alkalic phosphatase was incubated with the vector DNA for 30 min at RT. The alkalic 
phosphatase was subsequently inactivated by incubation at 85°C for 15 min. The products of 
ligation reaction were then used for transformation of competent bacteria. 
 
4.11.4 Preparation of competent cells 
Competent cell is a cell that is chemically treated to allow its membrane to be permeated by 
plasmids.  
A single colony of the required E. coli strain was picked and grown overnight in 2 ml 
of LB medium at 37°C. 0.3 ml of the cell culture was subcultured into 15 ml of LB medium 
supplemented with 1% (w/v) glycine and the culture was grown ~3 h at 37°C to get 
OD600=0.4-0.8. Cells were harvested by centrifugation (9 000×g; 5 min) and the pellet was 
ressuspended in 0.9 ml of fresh cold (4°C) LB medium supplemented with 1% (w/v) glycine. 
After, a brief incubation at 4°C, 0.1 ml of cold (4°C) Transformation buffer was added and 
mixed by inverting with the cell suspension. Competent cells were used for transformation 
directly or aliquoted (à 120 μl) and stored at -80°C until needed.  
 
LB medium   20g/l LB Miller Broth powder  
Transformation buffer 20% (w/v) PEG 2000; 0.96% (w/v) sodium citrate;  
4.92% (w/v) MgSO4, pH 5.5 
 
4.11.5 Transformation of bacterial cells by heat shock 
Transformation is the introduction of a plasmid into a competent cell. The plasmid will be 
replicated in the bacteria, which will copy the DNA of interest. Often the plasmid carries a 
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gene that makes the bacteria resistant to an antibiotic. Only the bacteria that carry the plasmid 
will grow on substrate containing appropriate antibiotic. 
Aliquots of competent cells were thawed out on ice. After addition of 1 µl of plasmid 
DNA or 10 µl of ligation mixture, cells were very gently mixed and incubated at 4°C for 20 
min. Cells were then exposed to heat shock at 42°C for 1 min, immediately supplemented by 
800 µl LB medium with 20 mM glucose, prewarmed to 37°C, and incubated in shaker at 37°C 
for 1 hour. After brief spinning (9 000×g; 5 min) and removing of majority of supernatant, 
cells were resuspended in the residual medium, plated on LB agar plate containing appropriate 
antibiotics and incubated overnight at 37°C.  
 
LB medium  20 g/l of LB Miller Broth powder 
LB agar plates 15 g/l of agar in LB medium  
 
4.11.6 Plasmid DNA purification from bacterial culture 
Plasmid DNA can be isolated from bacterial cultures using differential alkaline denaturation. 
In this method cells are lysed in presence of sodium dodecyl sulphate (SDS) and NaOH. Both 
chromosomal and plasmid DNA and proteins are denatured in this process but after the 
neutralization of the solution with sodium acetate only the plasmid DNA can re-anneal and 
stay dissolved in the solution. Chromosomal DNA and proteins stay in the complex with SDS 
and NaOH and are removed by centrifugation. Plasmid DNA can be then concentrated by 
precipitation with ethanol (Birnboim and Doly, 1979). 
Isolation of plasmid DNA was performed by either NucleoSpin® Plasmid purification 
KIT according to manual protocol or using “hand-made” purification according to following 
protocol. Colonies picked from agar plate were grown in 5 ml of LB medium with appropriate 
antibioticum overnight in shaker at 37°C. Next day, the cell pellet was resuspended in 250 μl 
of buffer S1. After incubation for 5 min at RT, 250 μl of buffer S2 was added, mixed by 
inverting and incubated for next 5 min at RT. 300 μl of buffer S3 was mixed with the cell 
suspension and incubated for 5 min at 4°C. Supernatant after centrifugation (16 000×g; 15 
min; 4°C) was mixed with 600 μl of isopropanol and incubated for 10 min at 4°C. Pellet after 
centrifugation (16 000×g; 15 min; 4°C) was washed by cold 75% ethanol and dried for 20 min 
at RT. Finally, the DNA pellet was resuspended in 50 μl of TE buffer.  
 
Buffer S1  50 mM Tris-HCl, pH 8.0; 10 mM EDTA; 20 mg/ml RNase A 
Buffer S2  200 mM NaOH; 1% (w/v) SDS 
Buffer S3  3 M sodium acetate, pH 4.8 
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TE buffer   10 mM Tris-HCl, pH 8.0; 0.1 mM EDTA 
 
4.11.7 Determination of DNA concentration 
Isolated DNA samples were qualitatively checked by agarose gel electrophoresis. The 
concentration was determined by measuring the absorbance at 260 nm using ND-1000 
Spectrophotometer . 
 
4.12 Baculovirus expression system 
The baculovirus expression system is based on the insertion of a foreign gene into 
nonessential region in the bacmid DNA via site-specific transposition using transfer vector 
pFastBac containing target gene. Thus gene of our interest is placed under control of strong 
polyhedrin promoter of the fall armyworm Autographa californica nuclear polyhedrosis virus 
(virus). The Spodoptera frugiperda (Sf9), cells are highly susceptible to infection by the 
virus. Proper insertion of the expression cassette into bacmid disrupts the lacZ gene 
encoding β-galactosidase and can be monitored as white colonies in the presence of a 
chromogenic substrate (X-gal) and the inducer IPTG. Transfection of the recombinant 
bacmid into insect cells leads to generation of recombinant baculovirus particles that will 
be amplified and used for protein expression.  
 
4.12.1 Preparation of bacmid DNA 
Recombinant baculovirus was generated using the Bac-to-Bac® Baculovirus Expression 
System (Invitrogen) (Figure 13). E. coli DH10Bac strain was then transformed by produced 
recombinant pFastBac vector to transpose the foreign DNA into bacmid. Cells were then 
grown on Luria agar plates. White colonies were selected and streaked on to a fresh plate to 
verify the phenotype. Recombinant bacmid DNA was isolated from the bacteria by “hand-
made” plasmid purification procedure (described in chapter 4.3.6) and used for transfection of 
Sf9 cells to produce recombinant baculovirus. 
 




Figure 13  Bac-to-Bac baculovirus Expression System (adapted from Invitrogen Instruction 
Manual 2002). 
 
4.12.2 Subculturing of Sf9 insect cells 
Sf9 cells were ordinarily grown in suspension in Grace´s medium supplemented with 
yeastolate and lactalbumin hydrolysate containing 10% (v/v) fetal bovine serum (FBS) and 
0.1% (v/v) pluronic F68 at 28°C in shaking incubator. Cells used for virus amplification were 
grown adherently in supplemented Grace´s medium containing 10% (v/v) FBS in incubator at 
28°C. Condition of the adherently growing cells was observed under light microscope Eclipse 
TS100. 
 
4.12.3 Transfection of Sf9 insect cells 
Transfection of Sf9 cells by bacmid DNA was performed as following. 5 μl of bacmid DNA in 
100 μl of supplemented Grace´s medium was added to 8 μl of Cellfectin II reagent in 100 μl of 
supplemented Grace´s medium and incubated 30 min at RT. This solution was afterwards 
dropwise added to adherently growing Sf9 cells (0.8×106) in 2 ml of supplemented Grace´s 
medium in 6-well plate and incubated for 3-5 hours. Then, cell medium was replaced by 
supplemented Grace´s medium containing 10% (v/v) FBS and incubated for 72 hours.  
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4.12.4 Virus amplification 
To amplify the virus titer after transfection, 0.8 ml of medium from cells was used for infection 
of another adherently growing Sf9 cells (8×106) in 10 ml of fresh supplemented Grace´s 
medium containing 10% (v/v) FBS in 25cm2-tissue culture flask. After incubation for 5-7 days, 
until the majority of cells lysed (Figure 14), the virus titer was amplified in larger volume in 
75cm2- or 150cm2-tissue culture flask. This process of amplification was repeated 3-4 times 
with increasing amount of cells to obtain sufficient quantity of virus for pilot and large-scale 
protein expression. Amount of medium containing virus for infection of cells varied according 
to the virus concentration. 
 
Supplemented Grace´s medium 3.3 g/l of yeastolate and 3.3 g/l of lactalbumin 
hydrolysate in Grace´s Insect Cell Culture Medium 
 
Luria agar plates  1.2% (w/v) agarose; 50 μg/ml kanamycin; 7 μg/ml 
gentamicin; 10 μg/ml tetracycline; 100 μg/ml X-gal;  
40 μg/ml IPTG, in LB medium 
 
 
Figure 14 Sf9 insect cells.  
(a) Normal non-transfected cells; (b) cells 72 h after transfection by recombinant baculovirus; (c) 
lysing cells 96 h after transfection. Original magnification ×200. Adopted from (Cui et al., 2007) 
 
4.13  Transfection of human cells by siRNA 
Small interfering RNA (siRNA) is a double-stranded RNA molecule involved in RNA 
interference (RNAi) pathway. RNAi is an evolutionary conserved process nowadays widely 
used in research as a tool for specific gene silencing.  
To facilitate siRNA uptake by human HEK293 and U2OS cells, Lipofectamine 
RNAiMAX, a lipid-based transfection reagent was used. 9 μl of Lipofectamine RNAiMAX in 
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250 μl of Opti-MEM was added to 4 μl of 40 uM siRNA in 250 μl of Opti-MEM and incubated 
15 min at RT. This solution was afterwards dropwise added to cells in 6-cm plates with 3.5 ml 
of DMEM medium (Dulbecco's Modified Eagle's Medium) supplemented with 10% (v/v) FBS 
and penicillin/streptomycin solution and incubated for 48 hours at 37°C, 5% CO2.  
 Whole cell extract (WCE) was prepared as followed. Cells were washed by 0.5 ml PBS 
and scraped into 100 μl of 2×SDS buffer. Samples were sonicated (amplitude 3 μm, 2×15 s, 
RT) and the protein concentration measured using bicinchoninic acid (BCA) protein 
determination assay. WCE samples were mixed with 10×DB buffer, boiled 5 min at 95°C and 
analyzed by SDS-PAGE (7% gel) and western blot. 
 
Complete DMEM medium DMEM medium; 10% (v/v) FBS; penicillin/streptomycin 
solution 
SDS buffer (4×)  250 mM Tris-HCl, pH 6.8; 8% (w/v) SDS; 40% glycerol 
DB buffer (10×)  400 mM DTT; 0.01% Bromphenol Blue  
 
4.14 Expression of recombinant proteins 
Nowadays, there is a number of efficient proteins expression systems. The choice of right 
system depends on many factors. Each expression system has its pros and cons. E. coli is one 
of the most widely used expression hosts. Expression of recombinant protein in prokaryotic 
system has advantages including ease of culture, very rapid cell growth, simple induction of 
protein expression by IPTG, etc. Disadvantages are common expression of a protein in 
inclusion bodies and dysfunction of an expressed protein due to the lack of posttranslation 
modifications. These inconveniences can be overcame by expression of a protein in eukaryotic 
system, such as expression in yeast or in Sf9 insect cells. This system is more time-consuming 
in comparison to prokaryotic system and requires more expensive facility. Pilot or small-scale 
protein expressions are ordinarily used for optimization of the process using all kinds of 
expression hosts. To produce higher quantities of a protein for further analysis, a protein is 
expressed in large-scale. 
 
4.14.1 Expression in bacterial cells 
Small-scale expression  
Single colony was picked out from LB agar plates and inoculated into 1-5 ml of LB medium 
containing appropriate antibiotic and incubated at 37°C for 2-3 hours until the optical density 
of the culture (OD600) reached ~0.5. Then the expression of protein was induced by addition of 
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0.1-1 mM IPTG for 2-36 h at 14-37°C. Concentration of IPTG, time and temperature of 
following incubation are varying, the exact expression condition of each experiment are 
described in the text in chapter 5.1.1. Cells were harvested by centrifugation (9 000×g, 5 min). 
According to further purpose, cell pellet was either directly boiled in appropriate volume of 
Laemmli buffer at 95°C for 5 min, or resuspended in appropriate volume of chitin-lysis buffer, 
sonicated (amplitude 10 μm, 2×10 s, 4°C) and centrifuged (16 000×g, 15 min, 4°C) to obtain 
soluble protein extract, which was afterwards boiled in Laemmli buffer at 95°C for 5 min. 
 
Chitin-lysis buffer 30 mM Tris-HCl, pH 8; 500 mM NaCl; 1 mM EDTA; 10% glycerol; 
0.1% Triton X-100 
 
Large-scale expression 
80 ml of overnight culture gained by inoculation of single E. coli colony from LB agar plate 
was diluted into 5 l LB medium containing appropriate antibiotics and grown at 37°C for 2 
hours. When the OD600 reached ~0.2, the cells were additionally incubated at 12°C for about 3 
hours. Protein expression was induced by 0.2 mM IPTG at the moment when OD600 reached 
~0.9 and then incubated at 12°C for 43 hours. Cells were harvested by centrifugation (300×g, 
35 min, 4°C) and the pellet was frozen at -80°C. 
 
4.14.2 Expression in Sf9 insect cells 
Small-scale expression 
25×106 insect cells grown in 25ml of supplemented Grace´s medium containing 10% (v/v) 
FBS and 0.1% (v/v) pluronic F68 in suspension were infected by 2.5 ml of medium containing 
virus. The cells were incubated for 2 or 3 days at 28°C on rotary shaker. Cells were collected 
by centrifugation (300×g; 5 min) and washed in PBS.  
The cell pellet was resuspended in 1.2 ml of GST-lysis buffer supplemented with 
protease inhibitor cocktail, sonicated (amplitude 10 μm, 2×15 s, 4°C) and centrifuged (16 
000×g, 45 min, 4°C). The obtained soluble protein extract was incubated with 0.2 ml of 50% 
glutathione (GSH)-agarose for 2 and 4 h at 4°C on rotary shaker. After binding, beads were 
collected by centrifugation (300×g, 3 min, 4°C) and washed four times by 1 ml of GST-
washing buffer. Beads were boiled in 2×Laemmli buffer at 95°C for 5 min and 10 μl aliquots 
of the elution fraction from the GSH agarose were subjected to SDS-PADE and western blot 
analysis. 
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Large-scale expression  
1.5×108 insect cells were infected by virus and incubated for 2 days at 28°C on rotary shaker. 
Cells were collected by centrifugation (300×g; 7 min) and washed in PBS. The cell pellet was 
frozen in liquid nitrogen and stored at -80°C until used.  
 
GST-lysis buffer 50 mM Tris-HCl, pH 8.0; 300 mM NaCl; 1 mM EDTA; 10% glycerol; 
2 mM DTT; 0.1% Triton X-100 
GST-washing buffer 0.2% (v/v) Triton X-100 in GST-lysis buffer 
 
4.15 Purification of recombinant proteins 
4.15.1 Chitin affinity chromatography 
Chitin affinity chromatography is based on the capture of chitin binding domain (CBD), the 
affinity tag, to beads coated by chitin (chitin beads). The great advantage of this purification 
system is that the target protein is released directly from the CBD-tag in presence of DTT, 
when the CBD undergoes specific self-cleavage resulting in elution of tag-freed protein.  
Cell pellet was thawed out on ice and resuspended in 35 ml chitin-lysis buffer 
supplemented with protease inhibitors [100mM PMSF, bestatin 1 ug/ml, pepstatin A 1 ug/ml, 
leupeptin 5 ug/ml, 1 mM sodium orthovanadate]. Cells were lysed by sonication (amplitude 14 
μm, 2×2 min, 4°C) and centrifuged (47 000 × g, 1 hour, 4°C) to gain soluble protein extract. 5 
ml of 50% chitin beads was added to the soluble protein extract and incubated at 4°C overnight 
on rotary shaker. The chitin beads were subjected to several washing steps until the protein 
concentration in flow through reached ~0. In total approximately 50 ml of chitin-lysis buffer 
was used for washing (centrifugation: 300×g, 5 min, 4°C). To cleave the protein from the 
chitin binding domain, firstly 5 ml of cleavage buffer was passed through the column to 
change the buffers, and then, 7 ml of the same buffer was incubated with the beads overnight at 
4°C on rotary shaker. After first elution, this procedure was further repeated 3 times to gain 
more protein from the beads. The elution fractions were frozen and stored at -80°C. Protein 
concentration was measured by Bradford method and purity was verified by SDS-PAGE. 
 
Cleavage buffer 40 mM Tris-HCl, pH 7.5; 100 mM NaCl; 1 mM EDTA; 50 mM DTT  
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4.15.2 GST affinity chromatography 
The principle of this method is based on high affinity of glutathione S-transferase (GST) to its 
substrate, GSH (tripeptide Glu-Cys-Gly). GST-tagged proteins are captured via the interaction 
with GSH immobilized to agarose beads. The target protein is then dissociated by addition of 
GSH, the binding competitor. 
Thawed cell pellet was resuspended in 7.5 ml of GST-lysis buffer containing protease 
inhibitor cocktail. Cells were lysed by dounce homogenizator. The soluble protein extract was 
obtained by centrifugation (47 000×g, 45 min, 4°C) and incubated with 2 ml of 50% GSH 
agarose for 2 or 4 h at 4°C on rotary shaker. Beads were washeded by >50 ml of GST-lysis 
buffer (centrifugation: 300×g; 5 min; 4°C). FBH1 protein was then eluted from the beads by 
GST-elution buffer containing 10-50 mM GSH.  
 
GST-elution buffer 40 mM Tris-HCl, pH 8.1; 50 mM NaCl; 10% glycerol 
 
4.15.3 Heparin affinity chromatography 
Heparin purification utilizes the ability of heparin to bind to DNA-binding proteins. 
Dissociation of these proteins from heparin, coupled to agarose beads, is performed by a high 
salt buffer. In our experiments, heparin purification was included as a second purification step 
after GST-purification. 
All elution fractions from previous purification step were mixed together and incubated 
with 0.5 ml 50% heparin beads for 1 hour at 4°C. After binding, beads were washed three 
times by Hep-buffer A and protein was eluted by Hep-buffer B. The heparin-elution fractions 
were mixed together and dialysed overnight in 1 l of dialysis buffer at 4°C. Purified protein 
sample was aliquoted (10μl), frozen by liquid nitrogen and stored at -80°C until used. All 
fractions from both purification steps were analysed by SDS-PAGE and western blot. Protein 
concentration was measured by Bradford and BCA methods.  
 
Hep-buffer A 40 mM Tris-HCl, pH 7.5; 0.1 M NaCl; 1 mM EDTA; 10% glycerol;  
1 mM β-mercaptoethanol 
Hep-buffer B 40 mM Tris-HCl, pH 7.5; 1 M NaCl; 1 mM EDTA; 10% glycerol;  
1 mM β-mercaptoethanol 
Dialysis buffer 40 mM Tris-HCl, pH 7.5; 50 mM NaCl; 1 mM EDTA; 40% glycerol;   
1 mM β-mercaptoethanol 
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4.16 Antibody production 
Antibodies, also known as immunoglobulins (Ig), constitute one of the principal effectors of 
the adaptive immune system. Due to their ability to bind an antigen with a high degree of 
affinity and specificity, antibodies constitute a powerful tool in a variety of medical and 
scientific disciplines. Antibodies are “Y” shaped proteins composed of heavy and light chains 
linked together by disulfide bonds. Depending on their structure and function, antibodies are 
classified into isotypes. In mammals, there are five antibody isotypes: IgG, IgM, IgA, IgD and 
IgE. In avians, there are three classes: IgY, IgM and IgA.  
There are several common ways to obtain antibody against protein of our interest. One 
can purchase a commercial antibody from a biotechnology company, receive it as a gift or 
produce it in laboratory. Animal species that are used for the production of antibodies include 
rabbits and mice, less often sheep, goats, chicken, horses, hamsters or guinea pigs. The 
selection of laboratory animal depends on numerous aspects, such as amount of antibody 
needed, purpose for which an antibody is needed, animal origin of the antigen, time demand of 
production procedure, requirements for breeding of the animals, skills and technology 
equipment requirements, and also costs.  
 
4.16.1 Extraction of total IgY antibodies from egg yolk 
Chicken eggs from immunized hen were collected, marked and stored at 4°C. In the isolation 
approach, first a total immunoglobulin mixture was isolated from individual egg as described 
(Gassmann et al., 1990) with some modifications.  
Briefly, the yolk (15 ml) was carefully separated from the white and the yolk skin and 
transferred into a falconi tube. The egg yolk was resuspended in 15 ml of IgY-buffer A and 
incubated on rotary shaker for 5 min at RT, subsequently mixed with 30 ml of IgY-buffer B 
and incubated under the same conditions. The precipitate was pelleted by centrifugation 
(3200×g, 30min, 4°C) and the resulting supernatant was clarified by centrifugation (3200×g, 
10 min, 4°C) and filtered. Solid PEG 6000 was added to the filtrate to a final concentration of 
12 % (w/v). The mixture was stirred until all PEG was dissolved. The solution was then 
centrifuged (3200×g, 30min, 4°C), the pellet containing IgY mixture was resuspended in 20 ml 
of IgY-buffer A and subsequently an equal volume of IgY-buffer C was added for second 
precipitation step. After incubation for 10 min at RT, the suspension was centrifuged (3200×g, 
30min, 4°C); the final pellet was resuspended in 12 ml of IgY-buffer A and dialyzed against 
large volume of the same buffer overnight at 4°C. Next day, the IgY mixture was clarified by 
centrifugation as above and filtered through membrane filter (0.2 μm).  
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IgY-buffer A  0.01 M KH2PO4, pH 7.2; 0.1 M NaCl 
IgY-buffer B  7% (w/v) PEG 6000 in IgY-buffer A 
IgY-buffer C  24% (w/v) PEG 6000 in IgY-buffer A 
 
4.16.2 Affinity purification of the antibody 
Isolation of specific IgYs was performed by affinity chromatography using 1 ml NHS-
activated agarose column with immobilized antigen. The activated agarose contains N-
hydroxysuccinimide (NHS) functional group that reacts with primary amines of a protein to 
form a stable amide linkage, especially at higher pH. Antigen specific antibodies captured in 
the column are eluted by low pH buffer. 
 
Preparation of column for affinity purification 
Antigen was dialyzed overnight against 1l of coupling buffer at 4°C. To immobilize the 
protein, the column was firstly activated by 3 × 2 ml of ice cold 1 mM HCl using peristaltic 
pump with flow rate 1 ml/min. Next, the antigen was loaded into the column by flow rate 0.5 
ml/min. Flow through was collected and subjected to second loading into the column with flow 
rate 0.1 ml/min. All remaining active groups were deactivated and non-specifically bound 
ligands were washed out by following procedure (flow rate used 0.5 - 1 ml/min):  
 
 injection of 3 × 2 ml of Buffer A 
 injection of 3 × 2 ml of Buffer B 
 injection of 3 × 2 ml of Buffer A 
 incubation of the column for 30 min at RT 
 injection of 3 × 2 ml of Buffer B 
 injection of 3 × 2 ml of Buffer A 
 injection of 3 × 2 ml of Buffer B 
 injection of 10 ml of Coupling buffer 
 injection of 10 ml of Elution buffer 
 injection of 10 ml of Regenerating buffer 
 injection of 10 ml of Coupling buffer 
 injection of 10 ml of ABB buffer 
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Affinity purification of anti-FBH1 the antibody 
The column with antigen bound to the NHS-activated agarose was employed for affinity 
purification of specific antibody from total IgY mixture. IgY suspension was loaded to the 
column and column was subsequently washed by 10 ml of ABB buffer by flow rate 0.25-0.5 
ml/min. Bound antibodies were eluted by low pH elution buffer. 1ml elution fractions were 
collected to tubes containing about 50 μl of 1.5 M Tris-HCl (pH 8.8) to adjust pH to ~8.6. The 
very low pH can cause protein denaturation. Protein fractions with more than 0.4 mg/ml 
protein concentration were mixed together as peak fraction and fractions with more than 0.1 
mg/ml protein concentration were mixed together as side fraction. Both were dialysed 
overnight against 1 l of dialysis buffer AB at 4°C. Finally, these antibody containing fractions 
were clarified by centrifugation (1000×g, 10 min, 4°C), aliquoted (10-50 μl) and stored at -
80°C until use.  
 
Coupling buffer  0.2 M NaHCO3, pH 8.3; 0.5 M NaCl 
Buffer A   0.5 M ethanolamine, pH 8.3; 0.5 M NaCl 
Buffer B   0.1 M sodium acetate, pH 4; 0.5 M NaCl 
Elution buffer  0.1 M glycine, pH 2.5; 100 mM NaCl 
Regeneration buffer  50 mM KH2PO4, pH 11.5; 100 mM NaCl 
ABB buffer   20 mM NaH2PO4; 100 mM NaCl, pH 7.5 
Dialysis buffer AB  40 mM Tris-HCl, pH 7.5; 100 mM NaCl; 10% glycerol 
 
4.17 Determination of protein concentration 
Two colorimetric methods were applied to estimate the concentration of protein in a solution, 
Bradford assay and bicinchoninic acid assay. In both methods, the amount of protein is 
quantified by measuring the absorbation and concentration of the sample protein is determined 
from a calibration curve derived from BSA standards of known protein concentration. 
 
4.17.1 Bradford protein determination assay  
Bradford assay is based on the proportional binding of Coomassie Brilliant Blue G-250 to 
proteins causing a visible color change (Bradford, 1976). The advantage of this method is quite 
easy handling where no heating is required. On the other hand, higher concentrations of 
detergents often present in protein samples may interfere with the assay. Different amounts 
(ordinarily 5-20 μl) of protein sample or BSA standard solutions (ordinarily 10 μl) were added 
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to 1 ml of 5x diluted Bradford Assay Reagent solution, mixed and transferred to plastic 
cuvettes. Absorbance was measured on spectrometer BOECO S-30 at 595 nm.  
 
Bradford Assay Reagent 0.01% Coomassie Blue G250; 0.475% (v/v) ethanol;  
0.85% (w/v) H3PO4 
 
4.17.2 Bicinchoninic acid protein determination assay 
Bicinchoninic acid assay (BCA) is based on reduction of Cu2+ to Cu1+ by protein in presence of 
bicinchoninic acid in alkaline environment (pH 11.25). The reaction produces purple-colored 
complexes (Smith et al., 1985).  
The working reagent was prepared by mixing of 49 parts of BCA solution with 1 part 
of 4% (w/v) CuSO4 · 5H2O solution. 200 μl of the working reagent was mixed with 10 μl of 
protein sample or BSA standard solution in 96well plate, which was then incubated at 37°C for 
30 min. The absorbance was measured at 560 nm using Multiscan EX spectrophotometer.  
 
BCA solution 2% (w/v) Na2CO3·H2O; 0.95% (w/v) NaHCO3; 0.16% (w/v) sodium 
tartarate; 0.4% (w/v) NaOH; 1% BCA sodium salt, pH 11.25 
 
4.18 Sodium dodecyl sulphate polyacrylamide gel 
electrophoresis 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) is a method used 
for separation of proteins according to their size. SDS is an anionic detergent that binds to 
proteins in constant weight ratio. Proteins heated in presence of SDS denature into their 
primary polypeptides and gain an overall identical negative charge density. These 
polypeptides, migrating in an electric field towards the positive anode, can be then separated in 
a polyacrylamide gel according to their size (Laemmli, 1970). 
Resolving gel was applied between two glass plates with spacer and overlaid with 
distilled water and kept in the stand at RT until polymerized. Then the water was removed, 
stacking gel was applied and the well-former was inserted. The gel was kept in the stand at RT 
until polymerized, placed into the tank and filled with 1×SDS-PAGE running buffer. The well-
former was removed. Protein samples were diluted in Laemmli buffer, boiled at 95°C for 5 min 
and loaded into the wells formed in the stacking gel. Electrophoresis was run at 80 V for 20 
min and then at 120 V for 1.5 - 2.5 hours. Gels were prepared according to following recepie: 
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Table 1  Composition of SDS-PAGE stacking and resolving gels 
 
 
Stacking gel (2.5 ml) Resolving gel (7.5 ml) 
4% 7% 8% 9% 10% 12% 
H2O [ml] 1.5 4.2 4.0 3.9 3.7 3.3 
1.5 M Tris-HCl,pH 8.8; 0.4% (w/v) SDS [ml] - 1.875 1.875 1.875 1.875 1.875 
0.5 M Tris-HCl,pH 6.8; 0.4% (w/v) SDS [ml] 0.63 - - - - - 
40% acrylamide/bis solution [ml] 0.25 1.3 1.5 1.7 1.88 2.25 
10% (w/v) SDS [μl] 25 75 75 75 75 75 
10% Ammonium persulphate [μl] 10 20 22.5 26 30 37.5 
TEMED [μl] 10 10 10 10 10 10 
 
 
Laemmli buffer (4×) 500 mM Tris-HCl, pH 6.8; 4% (w/v) SDS;  
40% glycerol; 40 mM DTT; 0.05% bromphenol blue 
SDS-PAGE running buffer (1×) 25 mM Tris-HCl, pH 8.3; 192 mM glycine;  
0.1% (w/v) SDS 
 
4.18.1 Staining of gels 
Coomassie staining 
Gels were stained in Coomassie solution at RT for 1 hour with agitation and destained 
afterwards in destaining solution at RT. 
 
Coomassie solution 0.1% (w/v) Coomassie Brilliant Blue R250; 10% acetic acid; 40% 
methanol 
Destaining solution 7.5% acetic acid; 10% isopropanol 
 
Silver staining 
Silver staining is a highly sensitive method with a detection level ~50 times lower than 
Coomassie staining, i.e. 0.3-10 ng of a protein. Detection depends on the binding of silver ions 
to the amino acid, followed by reduction to free metallic silver. The protein bands are 
visualized as spots on the gel where the reduction occurs (Kerényi and Gallyas, 1973).  
Gels were incubated in fixation solution for 20-60 min, then in 50% methanol for 10-
30 min and washed 3×10 min in H2O. Followed by incubation with 0.02% (w/v) sodium 
thiosulphate for 10 min and washing 2×5 min in H2O. Gels were stained by 0.1% (w/v) silver 
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nitrate for 20 min and rinsed 2×1 min in H2O. Proteins were visualized in developer solution 
and fixed in 5% acetic acid for 5-10 min. Stained gels were stored in H2O. 
 
Fixation solution 50% methanol; 5% acetic acid 
Developer solution 2% (w/v) Na2CO3; 0.04% (w/v) formaldehyde 
 
4.19 Western blot analysis 
Western blot is a method used for the identification and quantification of specific proteins. 
Proteins are usually first separated using SDS-PAGE and then transferred to a membrane by 
electric field. For immunodetection of proteins, the membrane is probed with primary and 
secondary antibodies against target protein and primary antibody, respectively. 
Separated proteins on polyacrylamide gel were first transferred to Amersham 
Hybond-P PVDF membrane using semi-dry transfer. Whatman filter papers and PVDF 
membrane (activated by incubation in methanol for 2 min) were soaked in transfer buffer and 
placed on anode in following order: 3 pieces of filter paper, PVDF membrane, gel, 3 pieces of 
filter paper, and covered by cathode. The transfer ran at 150 mA/gel for 1.5 h at RT. To check 
the transfer efficiency, the PVDF membrane was stained by Ponceau solution for ~10 min at 
RT. The membrane was blocked in 5% (w/v) non-fat dry milk or 3% (w/v) BSA in TBST for 1 
hour and incubated with primary antibody overnight at 4°C in ~2% (w/v) non-fat dry milk or 
1% (w/v) BSA in TBST. Next day, the membrane was washed three times with TBST for 15 
min at RT, incubated with corresponding horseradish peroxidase (HRP) conjugated secondary 
antibody for 1 hour at RT in ~2% (w/v) non-fat dry milk or 1% (w/v) BSA in TBST and 
washed three times with TBST for 15 min at RT. Then the PVDF membrane was soaked in 
enhanced chemiluminescence (ECL) reagent, covered with saran foil, exposed to X-ray film in 
dark room and developed in X-ray film processor Optimax 2010. 
 
Transfer buffer 0.1 M Tris-HCl, pH 7.5; 0.192 M glycine; 5% methanol 
Ponceau solution 0.1% (w/v) Ponceau S; 5% acetic acid  
TBST   30 mM Tris-HCl, pH 7.5; 150 mM NaCl; 0.05% (v/v) Tween-20  
 
4.19.1 Dot-blot analysis 
Dot-blot is a quick technique used to examine if an antibody recognizes target protein. The 
principle of this method is similar to common western blot analysis. Protein is directly applied 
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on the membrane and visualized by primary and secondary antibodies. Dot-blot may be also 
used to determine appropriate starting concentration of primary antibody for western blot. 
Antigen and BSA as a control were diluted into following series: 0.5, 1, 5, 25, 50, 125 
ng/μl, and gradually dropped (à 1 μl) onto activated Amersham Hybond-P PVDF membranes. 
Dried and blocked in 5% (w/v) non-fat dry milk in TBST (0.5-1 hour, RT) membranes were 
incubated with different dilutions of primary antibody in 0.5% (w/v) non-fat dry milk in TBST 
for 1.5 hour at RT and developed after incubation with secondary antibody as described in 
chapter 4.11. 
 
4.20 Protein-protein interaction study techniques 
4.20.1 Protein complex-immunoprecipitation 
Protein complex-immunoprecipitation (co-IP) is used to capture and determine a protein 
interacting with protein of interest. 
Mammalian cells grown to about 80% confluency in a 10-cm or 15-cm Petri dishes 
were washed by PBS and scraped into 0.5 or 1.0 ml of lysis buffer. Samples were vortexed and 
sonicated using Bioruptor 7-10×30s cycles. The cell lysates were clarified by centrifugation 
(16 000×g; 45 min; 4°C).  
For co-IP, 1 mg of the soluble protein extract was incubated with 200 ng of purified 
GST-FBH1-His6x, 3 μg of rabbit anti-RAD51 antibody or control rabbit IgG in a final volume 
of 0.5 ml of IP buffer for 4 h at 4°C on rotator. Then, 15 μl of Protein A/G PLUS-Agarose 
slurry was added followed by incubation for further 1 h under the same conditions. Beads were 
collected by centrifugation (300×g; 3 min; 4°C), washed 4 times by 1 ml of IP buffer and 
boiled with 12 μl of 2×Laemmli buffer at 95°C for 5 min. Samples were subjected to SDS-
PAGE on 9% gel and WB analysis. 
 
Lysis buffer 50 mM Tris-HCl, pH 7.5; 120 mM NaCl; 1 mM EDTA;  
0.5% (v/v) Nonidet P-40; 20 mM NaF; 0.5 mM sodium orthovanadate;  
15 mM sodium pyrophosphate; protease inhibitor cocktail  
IP buffer 50 mM Tris-HCl, pH 7.5; 120 mM NaCl; 20 mM NaF;  
15 mM sodium pyrophosphate; protease inhibitor cocktail  
 
4.20.2 GST pull-down assay 
Pull-down assay is in vitro method used for determination of bait-prey protein interaction 
where the bait protein is immobilized on beads through its affinity tag.  
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100 ng of RAD51K133R was incubated with 200 ng of purified GST-FBH1-His6x or 
200 ng of control (40 ng of GST + 160 ng of BSA) in a final-volume of 0.4 ml of NET-N150 
buffer or NET-N150 buffer containing 1mM DTT for 4 h at 4°C on a rotator. Then, 15 μl of 
GSH agarose beads slurry were added to the reaction samples and incubated for another 1 h at 
4°C on rotator. Beads were collected by centrifugation (300×g; 3 min; 4°C), washed 4 times by 
1 ml of NET-N150 buffer and boiled with 12 μl of 2×Laemmli buffer at 95°C for 5 min. 
Samples were subjected to SDS-PAGE on 9% gel and WB analysis. GST-FBH1-His6x and 
GST as a control were used in equimolar ratio. 
 
NET-N150 buffer 10 mM Tris-HCl, pH 8.0; 150 mM NaCl; 1 mM EDTA;  
0.2% (v/v) Triton X-100 
 
4.20.3 Far-western blot analysis 
Far-western blot is another in vitro technique to study protein-protein interaction. The 
procedure is similar to standard western blot analysis. Separated prey protein by SDS-PAGE is 
transferred on a membrane and probed with bait protein solution. The bait-prey interaction is 
visualized using anti-bait antibody.  
Far-western blot analysis was performed as described in (Selak et al., 2008). Purified 
recombinant proteins, 900 ng of RPA, 300 ng of RAD51K133R, and 750 ng of BSA were 
separated by SDS-PAGE on 12% gel and transferred to Amersham Hybond-P PVDF 
membrane. The membrane was blocked by 10% (w/v) non-fat dry milk in far-TBST for 1 hour 
and briefly washed by far-TBST. Membrane was then incubated in protein solution, 0.42 μg/ml 
of GST-FBH1-His6x or 0.14 μg/ml GST in 3 ml of hybridization solution, or in 10% (w/v) 
non-fat dry milk in far-TBST for 2 h at RT with agitation. Membranes were washed 3×15 min 
by far-TBST, incubated with rabbit anti-GST antibody overnight at 4°C and developed after 
incubation with secondary antibody as described in chapter 4.11. 
 
Far-TBST   30 mM Tris-HCl, pH 7.5; 150 mM NaCl; 0.3% (v/v) Tween-20 
Hybridization solution 0.25% (w/v) non-fat dry milk and 1 mM DTT in far-TBST 
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4.21 Enzymatic assays 
4.21.1 Malachite green ATPase assay 
Malachite Green ATPase assay provides an elegant and rapid way to observe ATPase activity 
of particular enzyme. This colorimetric assay is based on spectrophotometric quantification of 
inorganic phosphate (Pi) released after ATP hydrolysis (Figure 15). In presence of ammonium 
molybdate and malachite green the Pi forms a phosphomolybdenate-malachite green complex 
causing a visible color change.  
 
 
Figure 15  Scheme of ATP hydrolysis. 
 
Reaction mixtures (typically 20 μl) contained varying concentration (20-80nM) of 
ATPase enzyme (FBH1, FBH1D698N, or RECQ5β) in presence of different DNA structures. 
DNA structures used were single-stranded phagemid M13mp8.32, plasmid dsDNA in 
concentration of 25μg/ml and oligonucleotides, 25- and 37-mer , 53- and 93-mer in 1μM 
concentration. To check for residual phosphate in protein sample that could interfere with 
measurement, FBH1 was inactivated by incubation at 55°C for 20 min. Reactions were usually 
initiated by addition of ATP to a final concentration of 2-16 mM and terminated after 30 min 
incubation at 37°C by addition of one reaction volume of 0.1M EDTA (pH 8.0). 20 μl of 
reaction mixture was then two times diluted by H2O in a 96-well microplate. To that mixture, 
100 μl of ammonium molybdate solution and 50 μl of malachite green solution were added and 
incubated for few minutes before absorbance at 620 nm was measured in a microplate reader 
Multiscan EX spectrophotometer. The concentration of inorganic phosphate was determined 
from a calibration curve derived from solutions of known Pi concentration (KH2PO4). 
Reactions were done in duplicates in two or more independent experiments. 
 
ATPase buffer 50 mM Tris-HCl, pH 7.5; 50 mM NaCl; 2 mM MgCl2;  
1 mM DTT; 50 μg/ml BSA 
Ammonium molybdate solution  [2.32% (w/v) of (NH4)6Mo7O24 in 6 M HCl] diluted in 
H2O (ration 1:3) 
Malachite green solution  [5.72% (w/v) of malachite green in H2O] diluted in H2O 
(ratio 1:100) 
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4.21.2 Topoisomerase I-linked DNA topology modification assay 
Topoisomerase I-linked DNA Topology Modification Assay is an approach to examine the 
ability of a helicase to disrupt RAD51 from ssDNA region. In a brief description of the 
procedure (Figure 16): Relaxed plasmid DNA trap RAD51 molecules displaced from ssDNA 
by a DNA helicase. RAD51 also forms a helical nucleoprotein filament on dsDNA and thus 
forces it to adopt an extended conformation (Sung and Robberson, 1995). RPA has high 
affinity for ssDNA and can cope with RAD51 for binding to ssDNA. Binding of RAD51 to 
topologically relaxed covalently closed circular dsDNA induces lengthening of the DNA and 
formation of positive supercoils that can be observed as change in the DNA linking number 
after treatment with eukaryotic topoisomerase I. Positive supercoils in the plasmid DNA 
subsequently results in negative supercoiling after proteinase K treatment. The different DNA 
species present in the reaction: ssDNA, dsDNA in relaxed and supercoiled form, are separated 
by electrophoresis in agarose gel and visualized by ethidium bromide straining. 
 
Figure 16  Reaction scheme of Topoisomerase I-linked DNA topology modification assay. 
Single-stranded DNA, ssDNA; double-stranded DNA, dsDNA; Hel., helicase; TopoI, 




Reactions were carried out at 37°C in an final-volume of 25 μl of Buffer R 
supplemented with an ATP-regenerating system consisting of 10 U/ml creatine phosphokinase, 
12 mM creatine phosphate and 2 mM ATP. 2 μM RAD51K133R was preincubated with circular 
M13mp8.32 ssDNA (9 μM nucleotides) for 6 min, followed by addition of 150 nM RPA and a 
DNA helicase. Helicases used were: RECQ5β (80 and 160 nM), FBH1 (50, 160, 210, and 320 
nM) and FBH1D698N (320 nM). After a 6-min incubation, topologically relaxed pGEM-7Zf(+) 
DNA (7 μM base pairs) and 3 U of topoisomerase I were added to complete the reaction, 
which was then incubated for further 8 min. Reactions were terminated by addition of 5 μl of 
STOP buffer followed by 25-min incubation at 37°C. During this process, proteinase K present 
in the STOP buffer caused degradation of all proteins. DNA was thus released from the protein 
coat and could be evenly separated in the following step. Stopped reactions were mixed with 
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3.3 μl of 10×DNA loading buffer, resolved by 1% agarose gel electrophoresis in 0.5×TBE 
buffer at 100V for 1 h 45 min, stained in ethidium bromid solution (0.5 μg/ml) and visualized 
using a UV transilluminator.  
Signal of the particular bands was quantified using ImageJ software and the quantity of 
supercoiled DNA products was first expressed as a percentage of total dsDNA and then 
calculated as a percentage of the amount of product generated in the reaction carried out in the 
absence of helicase and RPA (Figure 34, line 3; - control, 0% of supercoiled DNA) and in the 
absence of ssDNA, helicase, and RPA (Figure 34, line 4; + control, 100% of supercoiled 
DNA). 
To generate topologically relaxed dsDNA, 4 μl of supercoiled pGEM-7Zf(+) DNA was 
incubated with 1.6 μg of E. coli topoisomerase I at 37°C for 30 min in 40 μl of Buffer R 
supplemented by 100 μg/ml BSA. This enzyme was then heat inactivated at 65°C for 10 min.  
 
Buffer R 25 mM Tris-HCl, pH 7.5; 50 mM KCl; 1 mM DTT;  
1 mM MgCl2; 100μg/ml BSA 
STOP buffer   6% (w/v) SDS; 0.1 M EDTA; 5 mg/ml proteinase K 
DNA loading buffer (10×) 0.25% (w/v) Bromophenol Blue; 50 mM Tris-HCl, pH 7.6;  
60% glycerol 









5.1 Anti-FBH1 antibody production 
5.1.1 Antigen production 
To produce the antigen for yield anti-FBH1 antibody, N-terminal part (1.27 kbp;         
1-484 aa) of the full-length human FBH1 (1-969 aa) gene encoding the isoform 4 was 
subcloned into the pTYB12 vector by PCR using the following set of primers: F  5´-catg gct 
agc atg gcc aaa agc aat tct gtt g -3´; R  5´- gca ctc gag ttc ggc ctg ctt tgc gat -3´, and following 
set of RE: Nhe I/Xho I. The antigen was expressed in bacteria as a fusion with N-terminal self-
cleavable affinity tag containing a chitin binding domain (CBD) [CBD-FBH1(1-484 aa)] 
(Figure 17).  
 
 
Figure 17  A schematic outline of FBH1 and of the antigen used for anti-FBH1 antibody 
production.  N-terminal fragment of full-length FBH1 containing F-box motif was expressed as a 
fusion protein with chitin binding domain (CBD) and used for antigen production. Violet box = F-
bow motif; red box = DNA helicase domain; bp, base pair. 
 
Antigen used for chicken immunization was prepared by Igor Chevelev, Ph.D. 
Immunization was performed in cooperation with Jiří Plachý, Ph.D., in an animal farm in 
Koleč. To purify antigen for affinity purification of the antibody, optimal conditions for 
antigen expression in soluble form were found by series of pilot expression experiments 
(Figure 18). Total and soluble cell extract of the lysed treated cells, alternatively total fraction 
of non-induced cells, were separated by SDS-PAGE. Antigen expression was first checked in 
XA90 bacterial cells. Protein expression was induced by addition of 1 mM IPTG followed by 
incubation at 37°C for 2 hours. The antigen was expressed under these conditions but was not 
present in soluble cytosolic fraction. Next we tried to decrease temperature and IPTG 
concentration and prolong time of expression to obtain soluble protein. We also compared 
antigen expression in two different bacterial strains, XA90 and BL 21. The expression level of 




However the antigen was not in soluble form. Under the conditions of 0.2 mM IPTG at 16°C 
for 20 hours, the antigen was present in soluble fraction in both strains, but not in a sufficient 
amount.  
In the next experiments, we thus further decreased the temperature and IPTG 
concentration and prolonged the time of protein induction to 36 hours. Finally, expression 
under the conditions of 0.1 mM IPTG at 14°C for 36 hours, and 0.2 mM IPTG at 14°C for 36 
hours, gave satisfying results in XA90 cells. Under these conditions, the antigen was present is 
soluble fraction at the same level as in total cell fraction. Expression level in BL21 cells was 
comparable with non-induced control.  
Large-scale expression of antigen was performed in XA90 cells using 0.2 mM IPTG 
and induction for 43 hours at 12°C. Antigen was purified by chitin affinity chromatography 
and five elution fractions of FBH1 antigen were collected (Table 2) and analyzed by 
SDS-PAGE (Figure 19). Finally, all antigen elution fractions were put together (5.26 mg in 





Figure 18  Optimization of FBH1 antigen expression. 
Cell fractions analysed by SDS-PAGE. Expression in XA90 and BL21 bacterial strains was 
induced by (a) 1 mM IPTG at 37°C for 2 hours; (b) 0.5 mM IPTG at 37°C for 2 hours, and 0.2 mM 
IPTG at 16°C for 20 hours; and (c) 0.1 mM IPTG at 14°C for 36 hours and 0.2 mM IPTG at 14°C 
for 36 hours. Total cell extract, T; soluble protein extract, S; non-induced cells, (-); HMW-SDS 





Figure 19  Large-scale expression and purification of FBH1 antigen. 
Total cell extract before, -control, and after induction of expression, Total; soluble protein extract, 
Soluble; flow through from chitin beads, FT; and five elution fractions are shown. PageRuler™ 




Table 2  Purification of FBH1 antigen by chitin affinity chromatography.  
Five elution fractions obtained after affinity purification of the antigen in large-scale.  
Elution 
fraction 






1. 11.5 0.204 2.35 
2. 5.0 0.128 0.64 
3. 7.0 0.148 1.04 
4. 7.0 0.104 0.73 
5. 5.5 0.092 0.51 
Pooled 
fractions 36.0 0.146 5.26 
 
 
5.1.2 Isolation and characterization of anti-FBH1 antibody 
Eggs from the immunized hen were collected and utilized for extraction of the 
antibody. First, a total immunoglobulin extract containing a mixture of various IgYs was 
isolated from ten egg yolks. In the next step, specific anti-FBH1 IgYs were purified by affinity 
chromatography utilizing purified FBH1 antigen immobilized on an NHS-activated agarose 




















Purified anti-FBH1 antibody was subjected to dot-blot analysis (Figure 20) using 
different amounts of the antigen (0.5 - 125 ng) and four different antibody dilutions (1:5 000-
1:100 000) to find optimal conditions. From these results we see, that the antibody recognizes 
antigen in a concentration dependent manner. We next wanted to examine the ability of the 
antibody to detect recombinant and endogenous FBH1 in extract from human cells (HeLa, 
U2OS, and HEK293). The expected position of endogenous FBH1 is approximately 110-140 
kDa. At this position, there is more than one band apparent on western blot of human cell 
lysates (Figure 21). Moreover, we observed that the antibody was bound non-specifically to 
other proteins in cell lysate. From this test, we chose the 1:50 000 antibody dilution as the 
working dilution, which was used in all following experiments.  
To distinguish which band represents endogenous FBH1 we employed a specific small-
interfering RNA (siRNA) to deplete endogenous FBH1 (Figure 22). We also included 
siLuciferase as a control and over-expressed exogenous FBH1 (GFP-FBH1). Samples were run 
twice on separate membranes and incubated with two different anti-FBH1 antibodies (newly 
purified and commercial mouse monoclonal anti-FBH1). To reduce the background caused by 
nonspecific binding, we tried to block the membrane using 3% (w/v) BSA solution instead of 
5% (w/v) dry milk in TBST, and additionally, 1% (w/v) BSA was added to both, primary and 
secondary antibody solution. We found that none of the bands on western blot disappeared 






Figure 20  Sensitivity test of purified anti-FBH1 antibody. 
Test of functionality and sensitivity of purified anti-FBH1 antibody. The FBH1 antigen and BSA as 
a negative control were dropped on PVDF membranes in decreasing amount as shown and 





Figure 21  Western blot analysis of human cell extracts using anti-FBH1 antibody. 
Lysates of human cell lines, HeLa; U2OS; and HEK293 were separated by SDS-PAGE and 
analyzed western blot using three dilutions (1:10 000; 1:50 000; and 1:100 000) of chicken anti-
FBH1 antibody. Positive control, + control, is expressed streptavidin-FBH1-His6× in Sf9 cell 






Figure 22  Ability of anti-FBH1 antibody to recognize FBH1.  
Western blot (WB) analysis of purified recombinant GST-FBH1-His6x (100 ng); HEK293 cell 
lysate with over-expressed GFP-FBH1 (30 μg); and HEK293 and U2OS cell non-transfected 
(whole cell lysate, WCE) or transfected with siFBH1 and siLuciferase, siLuc. Membranes were 
incubated with (a) chicken anti-FBH1 antibody or (b) commercial mouse anti-FBH1antibody. 
Analysed fractions were loaded in amounts as denoted in upper part (50 or 100 μg). Expected 
positions of FBH1 signal are: 135 kDa of GST-FBH1-His6x and GFP-FBH1; ~110 - 140 kDa of 






5.2 Production of full-length FBH1 and FBH1D698N proteins in 
insect cells 
The construct for expression of the full-length FBH1 gene, the shortest isoform (969 aa), was 
derieved from pFastBac-streptavidin-FBH1(2.9kbp)-His6x. The streptavidin tag was replaced 
with a GST tag using NheI and NdeI restriction enzymes. The created construct was used for 
transformation of DH10Bac E. coli cells containing bacmid DNA. Here, the subcloned DNA 
fragment was transposed into the bacmid downstream of polyhedrin promoter. Sf9 cells were 
transfected by the purified bacmid DNA to produce virus.  
Beside FBH1 we also produced the ATPase-dead variant of FBH1 protein 
(FBH1D698N). Numbering of the amino acid substitution is adopted from the longest isoform of 
FBH1 (1094 aa) used by Fugger et al. (2009) and does not correspond to numbering in the 
shortest isoform. In the shortest isoform, it is D573N (see supplement). For better order we 
kept the original numbering. Site directed mutagenesis was performed by Igor Chevelev, Ph.D.  
Both proteins were expressed as fusions with a GST tag at the N-terminus and a 
histidine (His6x) tag on the C-terminus. The resulting proteins were: GST-FBH1-His6x (here 




Figure 23  Schematic depiction of FBH1 proteins. 
Both, FBH1 (upper sequence) and ATPase defective mutant FBH1
D698N
 (bottom sequence), were 
expressed with glutathion S-transferase (GST, blue box) and histidine (His6x, orange box) affinity 
tags. F-box motif is displayed as violet box and DNA helicase domain as red box. Red asterisk 
denotes approximate position of amino acids (aa) substitution on the FBH1
D698N
 primary sequence. 
  
 
Transfection, virus stock amplification and large-scale protein expression (3-days) of 
FBH1 was performed by RNDr. Kamila Burdová. Protein was purified in two steps. Firstly, 
FBH1 was captured via GST tag to GSH agarose beads during 4h-incubation and subsequently 




contamination in the elution fractions caused by GST from insect cells (Figure 24, Table) we 
were forced to integrate second purification step by heparin affinity chromatography. 
Sufficiently pure FBH1 was obtained. Amount of protein was monitored by protein 
concentration determination in all fractions in both purification steps (Table 4). 
The FBH1 protein was tested for ATPase activity by malachit green assay and was 
found to be active (for details see chapter 5.3). Next we prepared new virus for expression of 
FBH1 and FBH1D698N. Expression efficiency of both proteins was compared by 2- and 3-days 
expressions in small-scale. Additionally, we examined minimal time necessary for sufficient 
binding of both proteins to GSH agarose by incubation for 2 and 4 hours (Figure 25). We 
found that both proteins are sufficiently expressed in 2 days in a soluble form, whereas after 3-
days expression cells were already lysed and protein released into the medium. Expression of 
soluble FBH1D698N was at least 2 times lower than that of FBH1. Both proteins were efficiently 
bound to the GSH agarose within 2 hours.  
Next, the FBH1D698N was produced in large-scale under the same conditions used for 
FBH1 production (Figure 26). The only exceptions were those conditions found as more 
profitable in the small-scale expression described above, e.g. 2-days expression and 2 hours of 
binding to GSH agarose. The total amount of purified FBH1D698N protein (~7.5 μg from 
2.5×108 insect cells) was considerably reduced in comparison to the FBH1 (~147 μg from 
1.5×108 insect cells) as summarized in Table 4.  
To compare purity of FBH1 and FBH1D698N, we analyzed 200 ng of each protein, by 
SDS-PAGE followed by silver staining (Figure 26). However FBH1D698N seems to be more 
contaminated, the amount of purified FBH1 and FBH1D698N in these fractions was comparable, 
even slightly higher in case of FBH1D698N. Nevertheless, for further enzymatic experiments we 





Figure 24  Large-scale expression and purification of FBH1.  
FBH1was isolated using GST (a, b) and heparin (c, d) affinity chromatography purification steps. Protein fractions were separated by SDS-PAGE (a, c) and 
analysed by western blotting (WB) using chicken anti-FBH1 antibody (b, d). Total cell extract, Total; soluble protein extract, soluble; flow through from GSH 
and heparin agarose, GST-FT and Hep-FT, respectively; particular elution fractions; former isolated FBH1 as a positive control, +control; mixed elution fractions 
from GSH agarose, GST-elu. pool; mixed elution fractions from heparin beads before dialysis, Hep-elu. pool; final FBH1 protein sample after dialysis, Final 
FBH; and heparin beads after elution, Hep-beads after elu., are shown. PageRuler™ Unstained Protein Ladder, M. Asterisk denotes oligomerization of FBH1. 






Figure 25  Production of FBH1 and FBH1
D698N
 proteins in small-scale. 
FBH1 (a) and FBH1
D698N
 (b) were expressed for 2 or 3 days. Soluble protein extract was incubated 
with GSH agarose for 2 hours (2h) and 4 hours (4h). Protein fractions were separated by SDS-
PAGE. 135kDa bands represent FBH1wt or FBH1
D698N
 protein. Total cell extract, T; soluble 
protein extract, S; flow through from GSH agarose upon 2 and 4 hours of incubation, FT-2h and 
FT-4h, respectively; PageRuler™ Plus Prestained Protein Ladder, M. GST contaminant is shown at 










 was isolated by two-step purification using GST (a, b) and heparin (c, d) affinity chromatography. Protein fractions were separated by SDS-PAGE 
(a, c) and analysed by western blotting (WB) using chicken anti-FBH1 antibody (b, d). Total cell extract, Total; soluble protein extract, soluble; flow through 
from GSH and heparin agarose, GST-FT and Hep-FT, respectively; particular elution fractions; GSH and heparin agarose after elution, GST- and Hep-beads after 
elu., respectively; mixed elution fractions from GSH agarose, GST-elu. pool; mixed elution fractions from heparin beads before dialysis, Hep-elu. pool; final 
FBH1
D698N
 sample after dialysis, final FBH1
D698N
; and PageRuler™ Unstained Protein Ladder, M,. Asterisk denotes oligomerization of FBH1
D698N
. GST 
contaminant is shown at position of 26 kDa. e) Comparison of 200 ng of purified FBH1 and FBH1
D698N
. Proteins were separated by SDS-PAGE followed by 




Table 4  Protein fractions of two-step purification of FBH1 and FBH1
D698N
 in large-scale. 
 
GST-purification step 
























extract 8.5 6.100 52.000 15.0 4.000 60.000 
Elution 1 0.5 0.231 0.116 0.5 0.170 0.085 
2 0.6 0.335 0.201 0.5 0.170 0.085 
3 0.5 0.369 0.185 0.5 0.150 0.075 
4 0.4 0.310 0.139 0.5 0.090 0.045 
5 0.4 0.268 0.107 0.5 0.050 0.025 
6 0.5 0.219 0.110 0.5 0.024 0.012 
7 0.5 0.167 0.084 0.5 0.001 0.005 
8 0.4 0.136 0.054 - - - 
9 0.5 0.140 0.070 - - - 
10 0.5 0.121 0.061 - - - 
11 0.5 0.094 0.047 - - - 
12 0.5 0.112 0.056 - - - 
Elution 
pool 5.0 0.120 0.6 3.5 0.093 0.325 
Heparin-purification step 
Elution 1 0.25 0.213 0.053 0.10 0.220 0.022 
2 0.50 0.209 0.105 0.10 0.058 0.006 
3 0.50 0.049 0.025 0.10 0.001 0.000 
4 - - - 0.10 0.000 0.000 
5 - - - 0.10 0.000 0.000 
Total 
elution 
pool 1.25 0.14 0.175 0.45  0.056 0.025 
Final 



































5.3 Characterization of ATPase activity of FBH1  
To check whether purified FBH1 is enzymatically active, we measured its DNA-dependent 
ATPase activity, which is a hallmark activity of any DNA helicase. The ability of FBH1 to 
hydrolyse ATP was investigated by malachite green assay.  
 We compared the enzymatic activities of FBH1 and RECQ5β (Figure 27). Inactivated 
FBH1 was included in these measurements to exclude that the detected activity is due to presence 
of phosphate in FBH1 sample. To rule out the possibility of contaminating enzymatic activity, 
FBH1
D698N
 was examined as well.  
 These experiments demonstrated that in the presence of ssDNA, purified FBH1 
catalysed ATP hydrolysis in a dose dependent manner. In comparison to RECQ5β, FBH1 
exerted 2-3 times lower activity. FBH1D698N did not show any ATPase activity. This 
observation ensured us that the observed ATP hydrolysis was derived exclusively from FBH1 


















ATPase activity measured by malachite green ATPase assay. Increasing concentrations (20-80 
nM) of FBH1 and RECQ5β were used in the reactions. Both controls, inactivated FBH1 and 
FBH1
D698N
, were present at 80 nM concentration. The plot bars display average of values from two 
or more independent experiments. Error bars indicate standard deviation about the mean.




The DNA-dependent ATPase activity of FBH1 was further characterized under 
different reaction conditions (Figure 28-30). In these experiments, the typical reaction 
conditions were: 40 nM FBH1, 25 μg/ml of ssDNA and 2 mM ATP, if not specified otherwise. 
First, we measured the ATPase of FBH1 at different ATP concentrations (0-16 mM) as shown 
in Figure 28. We observed that FBH1 displayed the maximal activity at 8 mM. 
To determine the DNA substrate preference, ssDNA, dsDNA (25 μg/ml) and four 
oligonucleotides of different length, 25-, 37-, 53-, and 93-nucleotides (1μM) were examined 
for their ability to support ATPase activity of FBH1 (Figure 29). The results confirmed that 
FBH1 preferentially acts on ssDNA. dsDNA and other oligonucleotides supported the ATPase 
activity of FBH1 less efficiently. We also examined the ability of FBH1 to utilize other NTPs 
and dNTPs, as energy source (Figure 30). We found that dATP could also serve as substrate 
for FBH1 with 77% efficiency compared to ATP. Other nucleotides were hydrolyzed poorly 




Figure 28  ATPase activity of FBH1 at different ATP concentrations. 
ATP was present at concentrations (0; 0.5; 2; 8; and 16mM) in the reactions. The plot bars indicate 
average of values from three independent experiments. Error bars represent the standard deviation 


















Figure 29  ATPase activity of FBH1 in the presence of different DNA substrates. 
Single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA) plasmid DNA in 25 μg/ml 
concentration, oligonucleotides in length of 25-, 37-, 53-, and 93-nucleotides in 1 μM concentration 
were used as DNA substrates. 40nM FBH1 helicase was used in all reactions. The values in this 
experiment are related to concentration of released Pi upon hydrolysis of ATP in presence of 
ssDNA. The data presented are the average of three independent experiments. Error bars represent 








Figure 30  Ability of FBH1 to utilize NTPs or dNTPs as an energy source. 
Different nucleotide cofactors, NTPs (ATP, GTP, CTP and UTP) or dNTPs (dATP, dGTP, dCTP 
and dTTP) were present at 4 mM concentration in reactions. The values in this experiment are 
related to concentration of released Pi upon hydrolysis of ATP. The plot bars display average of 
values from two or more independent experiments. Error bars represent the standard deviation 



















































5.4 Protein interactions study 
In an attempt to identify novel interaction partners of FBH1 helicase, we first decided to 
investigate its interaction with RAD51. Due to the fact that we were not able to detect 
endogenous FBH1 by western blotting, we were forced to rely on experiments with 
recombinant FBH1. For this purpose, we used a protein complex-immunoprecipitation (co-IP) 
assay using the GST-FBH1-His6x protein, which was added to cell extracts. In this approach, 
FBH1 protein was captured via endogenous RAD51 protein from HEK293 or U2OS human 
cells by anti-RAD51 antibody. Control IgG were used as a control of nonspecific binding of 
RAD51 and FBH1 to the beads. Proteins bound to beads were examined by western blotting 
(Figure 31). These results indicate that FBH1 interacts with RAD51, however the interaction 
seems to be very weak.  
 
 
Figure 31  Co-immunoprecipitation of FBH1 with RAD51 from human cells extracts. 
GST-FBH1-His6x (FBH1) protein was incubated with HEK293 cell lysate containing anti-RAD51 
antibody or IgG as a control. Immunoprecipitated proteins bound to beads were eluted and 
analyzed by western blotting (WB) using chicken anti-FBH1and rabbit anti-RAD51antibodies. 
FBH1 (20%) and HEK293 cell lysate (5%) were loaded as input.  
 
 
 Next, we wanted to examine whether the observed interaction is direct or mediated by 
another protein. To prove this, we decided to perform pull-down assay using recombinant 
proteins, the GST-FBH1-His6x and human RAD51K133R. The RAD51K133R is ATPase-defective 
mutant of RAD51 and is more suitable for experiments with nucleoprotein filament described 




available in our laboratory. In the interaction studies, the mutant is believed to behave the same 
as RAD51wt because ATPase motifs are not involved in protein-protein interactions. 
 The principal aim of the pull-down approach in this experiment is to pull-down 
RAD51K133R protein via its interaction with FBH1, which is captured to beads through the GST 
tag. GST protein in equimolar concentration was used as a control. As demonstrated in 
Figure 32, we confirmed that FBH1 physically interacts with recombinant RAD51K133R protein, 
however this interaction is weak. Additionally, reducing conditions increased the binding 
efficiency to GSH agarose.  
 
 
Figure 32  Direct physical interaction between FBH1 and RAD51. 
Pull-down experiment with recombinant proteins. RAD51
K133R
 was incubated with GST-FBH1-
His6x (FBH1) protein or GST as a control and GSH agarose beads in buffer with or without DTT, 
+DTT and -DTT, respectively. Elutions from the GSH agarose were separated by SDS-PAGE and 
analysed by western blotting (WB) using chicken anti-FBH1 and rabbit anti-RAD51 antibodies. 
FBH1 (40%) and RAD51 (5%) were loaded as input.  
  
  
 Next, we decided to examine interaction between FBH1 and RPA. As mentioned in 
chapter 2.2.2, RPA is heterotrimeric complex composed of three subunits (RPA70; RPA30; 
and RPA14). To see which of these subunits interacts with FBH1, we decided to use another in 
vitro approach to analyze direct protein-protein interactions, far western blotting technique. 
Beside RPA, we also included the RAD51K133R protein and BSA. Prey proteins (RPA, 
RAD51K133R and BSA) were separated by SDS-PAGE and transferred to membrane. The 
membrane was incubated in solution of GST or GST-FBH1-His6x, the bait protein. The 




interacts with the largest subunit of RPA complex, RPA70 (Figure 33). Weak interaction 




Figure 33  Far-western blot analysis of interaction between FBH1 with RAD51 and RPA.  
RAD51
K133R
, RPA and BSA recombinant proteins were separated by SDS-PAGE and transferred to 
membrane. Membrane pieces were incubated with solution of bait protein: a) GST; b) GST-FBH1-
His6x; and c) solution containing no bait protein. All membranes were incubated with rabbit anti-
GST antibody. Position of RAD51
K133R





5.5 Analysis of FBH1 action on RAD51 nucleoprotein filament 
The main aim of this project was to determine the function of FBH1 helicase on RAD51 
nucleoprotein filament. To examine this task, we employed Topoisomerase I-linked DNA 
topology modification assay that allows detection of free RAD51 molecules in solutions.  In 
our experiments, we used the RAD51K133R, which has been shown to form stable nucleoprotein 
filaments in an ATP-bound state (Chi et al., 2006). We tested RAD51 disruption activity with 
increasing concentrations (50, 160, 210, and 320 nM) of FBH1 (GST-FBH1-His6x). Observed 
activity was compared to RECQ5β helicase, which is known to exert anti-recombinase activity 
(Schwendener et al., 2010). The purified FBH1D698N mutant, which lacks the capability to 
hydrolyse ATP and thus function to act as a helicase (Figure 27) was employed as negative 
control. 
 In presence of FBH1, as well as of RECQ5β, we can see concentration-dependent 
formation of supercoiled dsDNA products (Figure 34). This is not true in presence of 
FBH1D698N, which has no effect on supercoiled DNA generation. Compared to RECQ5β, 
FBH1 exerts 3 times lower RAD51K133R filament disruption activity. Our results thus provide 








Figure 34  RAD51
K133R
 nucleoprotein filament disruption activity of FBH1. 
a) Representative image of the effect of RECQ5β, FBH1 and FBH1
D698N
 on the stability of RAD51
K133R
 
nucleoprotein filament in agarose gel. b) Quantification of the intensity of the supercoiled DNA. Single-
stranded DNA, ssDNA; double-stranded DNA, dsDNA; TopoI, topoisometase I. The chart under the gel 
displays the average values from three independent experiments. Error bars represent the standard 






In the process of regulation of HR, FBH1 is known to inhibit accumulation of RAD51 
at sites of DNA damage and thus suppresses recombination events (Fugger et al., 2009, 
Morishita et al., 2005). However, the molecular mechanism of how FBH1 acts as an 
antirecombinase is still unresolved issue. In this thesis, we have brought a new insight into the 
mechanism of FBH1 function.  
We have produced the full-length human FBH1 protein in insect cells and 
characterized its enzymatic activities. To detect FBH1, we have raised chicken polyclonal 
antibody against an N-terminal fragment of human FBH1. We have investigated physical 
interactions of FBH1 with RAD51 and RPA. Moreover, we have examined whether FBH1 
possesses the ability to disrupt RAD51 nucleoprotein filament. 
Due to low quality of commercially available anti-FBH1 antibody, we decided to 
produce it on our own. Chicken species was chosen because they offer a number of 
advantages, among them are the possibility to quite easily harvest a large amount of antibodies, 
phylogenetic divergence from humans and low costs of hens breeding. We examined 
expression of various parts of FBH1 in E.coli but almost all gave either no expression or were 
produced into inclusion bodies (data not shown). The best results were obtained with N-
terminal fragment (1-484 aa) of FBH1, so we decided to use this fragment as an antigen for 
antibody production, although the choice to produce antigen containing a highly conserved the 
F-box protein motif was quite risky. This protein was highly insoluble when expressed in 
bacteria at 37°C but a series of pilot expressions revealed appropriate conditions to yield the 
antigen in soluble form (Figure 18). 
When used for western blotting, affinity-purified anti-FBH1 antibody could clearly 
detect purified recombinant full-length FBH1 protein (80 ng) and FBH1 ectopically expressed 
in human cells (Figure 22). However, in accordance with previous studies, we were not able to 
detect endogenous FBH1 (Figure 21, 22) (Kim et al., 2002, Fugger et al., 2009). This is 
probably due to a very low cellular concentration of FBH1. Fugger et al. (2009) observed that 
over-expressed FBH1 appears to be toxic to cells (Fugger et al., 2009). Thus it seems that 
FBH1 levels are tightly regulated in the cells to prevent deleterious effect of FBH1 on DNA 
metabolism.  
We set up a protocol for large-scale production of full-length FBH1 (1-969 aa), the 
isoform 4, in insect cells using baculovirus expression system. Isoform 4 was the only isoform, 




proteins were expressed as fusions with GST (N-terminus) and His6× (C-terminus) tags 
(Figure 23) and purified from the soluble cell extract. Cells were not sonicated to avoid 
binding of DNA from Sf9 cells to purified FBH1 protein. Large-scale expression of FBH1 was 
performed for three days, and we obtained high quantity of purified protein (Figure 24). After 
that we examined the expression efficiencies of both protein variants in small-scale (Figure 
25). We compared expression levels and solubility of protein 2-3 days after infection and 
found that the cells were already lysed by the third day. So, cells from large-scale expression 
of FBH1D698N were harvested 2 days after infection (Figure 26). Strikingly, there was an 
enormous difference in the protein yield between the two FBH1 variants. 
 Purification of FBH1 and FBH1D698N was performed under the same conditions. The 
only exception was the time range for binding to GSH agarose. In small-scale production we 
found out that both proteins are fully bound within 2 hours (Figure 25). The less time a protein 
spends in surrounding of cell lysate rich for numerous proteases, the better. Due to high level 
of contamination by GST after GST-affinity purification, we were forced to integrate an 
additional purification step. The His6x tag on the C-terminus was originally supposed to be 
utilized for purification. However, because of poor binding of the recombinant FBH1 proteins 
to nickel agarose (data not shown), we decided to use heparin affinity chromatography for 
purification. Heparin has the ability to bind proteins that interact with DNA. That is what 
FBH1 does whereas GST does not. This allowed us to obtain sufficient quantities of pure 
proteins for biochemical analyses. However, the protein yield of FBH1D698N was substantially 
lower, about 5% of FBH1 yield, even though the cell number was about 60% higher (Table 4). 
There are several possible explanations of this expression variability. Most probably, it was 
caused by different virus stock titer that was used for infection because we did not exactly 
determine the concentration of infectious virus in our stocks. So, in our approach, the virus 
titer was either too weak to give sufficient expression level, or vice versa, it was too 
concentrated that the cells were already lysed by the day of harvesting and protein was released 
to medium. Secondly, we should not omit the possibility that even a single amino acid 
mutation in a protein can cause improper folding of the protein. This is consistent with our 
observation that the purified FBH1D698N variant was slightly degraded (Figure 26). 
By means of malachite green ATPase assay, we proved that purified FBH1 is an active 
enzyme (Figure 27). The ATPase defective form of FBH1, FBH1D698N, was created to 
demonstrate that this activity is not caused by any co-purified enzymatic contamination. We 
showed that in comparison to RECQ5β, a well-characterized antirecombinase. FBH1 exerts 2-
3 times lower ATPase activity than RECQ5β under the same conditions. This may be a 




 In agreement with previous studies (Kim et al., 2004), we found that FBH1 
ATPase activity was stimulated by ssDNA, but not by dsDNA (Figure 29). Relatively high 
ATPase activity observed with FBH1 in the presence of supercoiled plasmid DNA can be 
explained by the presence of ssDNA regions in DNA substrate. To prove this hypothesis, we 
linearized plasmid by restriction enzymes and this activity was lost (observation by RNDr. 
Kamila Burdová). Partial activity in absence of any additional DNA may be caused by co-
purified ssDNA in the FBH1 sample. Our results also confirmed that ATP/dATP is the most 
utilized energy source of FBH1 as in case of majority of DNA helicase. Other NTPs or dNTPs 
were hydrolyzed poorly by FBH1 (Figure 30).  
In an effort to find novel interaction partners of FBH1, we first sought to investigate 
the interaction between FBH1 and RAD51, a key player in homologous recombination. Since 
we were not able to detect endogenous FBH1 in cell lysate by western blotting, we settled for 
interaction studies in vitro using purified recombinant FBH1. Using co-IP and pull-down 
assays, we revealed that FBH1 physically interacts with RAD51. We were able to 
immunoprecipitate recombinant FBH1 via endogenous RAD51 from human cell lysate (Figure 
31). By means of the pull-down assay, the recombinant RAD51K133R was pulled down via 
recombinant FBH1 (Figure 32). Since the functional mutation in the RAD51K133R does not 
affect its protein binding properties, we can conclude that FBH1 directly interacts with RAD51 
as well. However, it should be noted that the observed interaction is very weak. It is possible 
that the proper recognition and interaction between FBH1 and RAD51 is triggered upon 
occurrence of DNA damage and requires a posttranslational modification that is missing in our 
in vitro system. Below, we provide another explanation for this observation. Interestingly, in 
the pull-down experiments, we observed that DTT enhances binding of FBH1 to GSH agarose 
via the GST-tag. DTT maintains a reducing environment and thus prevents formation of 
disulfide bonds that may affect binding properties of GSH agarose.  
By immunofluorescence, it was shown that FBH1 colocalizes with RPA in nuclei of 
human cells (Fugger et al., 2009). This observation together with a note in the study by of 
(Kim et al., 2004) that FBH1 interacts with RPA in yeast two-hybrid system led us to examine 
FBH1-RPA interaction using purified recombinant proteins. By far-western blotting, we found 
that FBH1 was bound specifically to the largest subunit of RPA, RPA70 (Figure 33).  
Formation of RAD51 nucleoprotein filament on ssDNA is a key step in homologous 
recombination that is essential for pairing and strand exchange of homologous DNA molecules 
(Sung and Robberson, 1995). FBH1 has been implicated in the control of the RAD51 action 
(Chiolo et al., 2007, Fugger et al., 2009). Since FBH1, as an F-box protein, forms a functional 




filament by a unique mechanism based on RAD51 ubiquitination targeting the protein for 
degradation. The identity of the physiological substrate of the SCFFBH1 complex is still 
unresolved question. However, the finding that the level of endogenous RAD51 was 
unaffected in upon FBH1 over-expression argues against this kind of mechanism (Fugger et 
al., 2009). 
It has been suggested, although not yet experimentally proven, that FBH1 utilizes its 
translocase activity to inhibit the nucleoprotein filament formation. The core objective of this 
thesis work was to investigate the ability of FBH1 to displace RAD51 from the ssDNA. Using 
Topoisomerase I-linked DNA topology modification assay, we demonstrated that FBH1 is 
indeed able to dislodge RAD51 from nucleoprotein filament in vitro (Figure 34). Evidence that 
active translocation of FBH1 on ssDNA is required for this function comes from our finding 
that ATPase-dead mutant of FBH1, FBH1D698N, lacks this activity. Nevertheless, the filament 
disruptions activity of FBH1 was found to be ~3 times lower than that of RECQ5β helicase. 
This may be explained by the fact that RECQ5β as a member of SF2 family of helicases 
utilizes another, probably more efficient, mechanism to translocate along the DNA. 
In our experiments, we observed an additional band, which migrated at the position 
between ssDNA and relaxed dsDNA on the agarose gel. Our explanation of this unexpected 
band is that the ssDNA was probably contaminated by double-stranded form of this DNA.  
To summarize our finding from protein interaction and enzymatic studies of FBH1, we 
compiled a potential model suggesting a mechanism of how FBH1 controls the nucleoprotein 
filament function (Figure 35). According to this model, FBH1 is recruited to the ssDNA 
regions covered by RAD51 recombinase. FBH1 then translocates along the ssDNA and 
functions as an “ice-breaker” catalyzing the cleaning of RAD51 polymers from the DNA. For 
this action, FBH1 utilizes the free energy from ATP hydrolysis, which is required for its DNA 
helicase/translocase activity. Displacement of RAD51 molecules from ssDNA might by 
stimulated by the FBH1-RAD51 interaction. In the next step, RPA is recruited to the 
uncovered ssDNA regions to prevent re-loading of free RAD51. The binding of RPA to 
ssDNA might be also promoted via the FBH1-RPA70 interaction. It is worth to mention that a 
strong interaction between FBH1 and RAD51 is not welcome in this case. It is rather a 
dynamic relationship than tight binding because the particular RAD51 molecules need to be 
removed.  
Whether FBH1 acts according to our model remains to be further investigated. It is 
possible that FBH1 inhibits the nucleoprotein filament formation to suppress excessive HR 
events and hence prevent production of unwanted crossovers and interference of the HR 




function of FBH1 is required at sites of stalled replication forks where ssDNA gaps or DSBs 
are generated and can thus lead to loading of RAD51 recombinase and promote unscheduled 
recombination reactions (Barbour and Xiao, 2003). This idea is supported by the experimental 
data obtained from studies with Fbh1 in S. pombe. It was shown that Fbh1 suppresses 
spontaneous nucleoprotein filament formation, which can lead to accumulation of 
recombination intermediates (Morishita et al., 2005).  
Another DNA helicase, which is known to disrupt RAD51 from ssDNA, is the 
S. cerevisiae Srs2 (Krejci et al., 2003, Veaute et al., 2003). Srs2 shares several similarities with 
FBH1 and belongs to the same family as FBH1. All three antirecombinases, FBH1, RECQ5β 
and Srs2 have been shown to physically interact with RAD51 recombinase (Antony et al., 
2009, Schwendener et al., 2010). According to current presumption for Srs2, the protein-
protein interaction allosterically triggers the ATP hydrolysis within the RAD51 nucleoprotein 
filament resulting in the RAD51 dissociation (Antony et al., 2009). It is possible that similar 
mechanism accounts for FBH1. Since there is no apparent human homolog of Srs2, it is 
therefore tempting to speculate that FBH1 might be the functional and mechanistic homolog of 
Srs2 in humans.  
It should be emphasized that in all our experiments, only the shortest isoform of FBH1, 
isoform 4, was used. Thus, it is possible that the other isoforms may exert different phenotype. 
The longest isoform, isoform 1, containing a 125-aa extension at the N-terminus should be 
examined in future experiments. The ability of FBH1 to dislodge RAD51 from ssDNA should 
be further tested by visualization of nucleoprotein filament using electron microscopy. Another 
approach to check for the antirecombinase activity in vitro is a pull-down assay with ssDNA 
fragment linked to agarose beads. To elucidate the FBH1 mechanism in more detail, it is 
necessary to investigate which domain of FBH1 is responsible for the interaction with RAD51. 
It would be interesting to test if the direct interaction between FBH1 and RAD51 stimulates the 
nucleoprotein filament disruption activity of FBH1. More knowledge is needed to understand 
the role of FBH1 as an antireconbinase. For instance, it is not clear how does FBH1 distinguish 
between appropriate and inappropriate RAD51 nucleoprotein filaments. Why does the cell 
require several anrirecombinases and what is the interplay between each other? Or, where in 
the cell and under which circumstances does FBH1 operates? As a component of SCF 
complex, FBH1 is endowed by a great ability to target proteins for degradation. It is therefore 
highly interesting to speculate about the identity of the physiological substrates of SCFFBH1 









Figure 35  A potential model representing the mechanism of the FBH1 action on RAD51 
nucleoprotein filament. FBH1 catalyzes disruption of RA51 nucleoprotein filament via 
translocating along the single-stranded (ssDNA). The reaction is supported by a dynamic 
interaction between FBH1 and RAD51. The freed ssDNA regions are captured by the ssDNA-
binding protein, RPA, to prevent re-loading of RAD51. The recruitment of RPA is stimulated by 







 N-terminal fragment of human FBH1 spanning amino acids 1-484 was expressed, 
purified and utilized to raise chicken polyclonal anti-FBH1 antibody. Purified antibody 
specifically recognizes recombinant FBH1. However, we failed to detect endogenous 
FBH1.  
 
 Wild type and ATPase dead forms of FBH1 were expressed and purified from 
baculovirus-infected Sf9 insect cells. We confirmed that FBH1 is a ssDNA-stimulated 
ATPase. 
 
 We found that FBH1 physically interacts with RAD51 and the largest subunit of RPA 
(RPA70) in vitro. The interaction with RAD51 is very weak.  
 
 We experimentally showed that FBH1 has the ability to disrupt RAD51 nucleoprotein 
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      781 gnhqsgirgd akgqvallsr tnanvfdeav rvtegefpsr ihliggiksf gldriidiwi 
      841 llqpeeerrk qnlvikdkfi rrwvhkegfs gfkryvtaae dkeleakiav vekyniripe 
      901 lvqriekchi edldfaeyil gtvhkakgle fdtvhvlddf vkvpcarhnl pqlphfrves 
      961 fsedewnlly vavtrakkrl imtkslenil tlageyflqa eltsnvlktg vvrccvgqcn 
     1021 naipvdtvlt mkklpitysn rkenkggylc hscaeqrigp lafltaspeq vramertven 
     1081 ivlprheall flvf 
 
Figure S  Amino acid sequence of FBH1. 
Amino acid (aa) sequence of FBH1 isoform 1 (1094 aa); FBH1 isoform 4 (NCBI Reference 
Sequence: NP_001245382.1) with 969 aa is denoted by grey background. Position of the amino acid 
substitution in FBH1D698N is highlighted in blue (Internet source 1).  
 
 
